| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P OTUD4 USP17L22 USP17L15 USP17L21 USP17L20 PSMD7 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 4.33e-17 | 124 | 403 | 24 | GO:0101005 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P OTUD4 USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 7.50e-17 | 114 | 403 | 23 | GO:0004843 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P OTUD4 USP17L22 USP17L15 USP17L21 USP17L20 PSMD7 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 4.75e-16 | 137 | 403 | 24 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P OTUD4 USP17L22 CTSK USP17L15 USP17L21 USP17L20 PGPEP1 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 1.40e-13 | 192 | 403 | 25 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L1 ERMP1 USP17L4 USP17L24 USP17L5 PM20D1 CPD USP17L6P OTUD4 USP17L22 CTSK USP17L15 USP17L21 RELN ERAP1 USP17L20 ADAM20 PGPEP1 PSMD7 USP17L19 USP17L18 PMPCA USP17L17 PAN2 USP17L3 ADAMTS18 USP17L13 CNDP1 DPP6 USP17L2 RHBDF1 USP17L12 USP17L11 USP17L10 ADAMTS13 USP6 TLL1 USP17L8 | 1.69e-09 | 654 | 403 | 39 | GO:0008233 |
| GeneOntologyMolecularFunction | collagen binding | COL14A1 SPARCL1 HSPG2 NID2 ITGA11 FN1 CTSK ITGA1 ITGA9 DDR1 TLL1 | 6.75e-07 | 81 | 403 | 11 | GO:0005518 |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 2.09e-05 | 29 | 403 | 6 | GO:0005540 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | THSD4 COL6A5 COL14A1 HSPG2 NID2 COL7A1 FN1 VCAN RELN IMPG1 COL21A1 IMPG2 LAMA2 PAPLN | 2.97e-05 | 188 | 403 | 14 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 ENPP3 DYSF FAT1 EEF2K SPARCL1 HSPG2 NID2 VLDLR CLSTN1 VCAN CLSTN3 PCDHA9 CDHR2 CDH23 IQGAP1 ITPR2 STAB1 CABYR LPCAT2 ASTN2 CACNA1B FAT4 PCDHGB6 PCDHGA1 ADAMTS13 PLA2G4E USP6 TLL1 PADI6 CDH8 CDH17 | 5.88e-05 | 749 | 403 | 32 | GO:0005509 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 3.16e-04 | 17 | 403 | 4 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 3.16e-04 | 17 | 403 | 4 | GO:0019198 | |
| GeneOntologyMolecularFunction | histone H2AQ104 methyltransferase activity | 4.06e-04 | 2 | 403 | 2 | GO:1990259 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 6.26e-04 | 9 | 403 | 3 | GO:0098634 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P OTUD4 USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 2.94e-15 | 125 | 398 | 22 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P OTUD4 USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 6.22e-14 | 144 | 398 | 22 | GO:0070646 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | THSD4 PDGFRA COL14A1 POMT2 HSPG2 NID2 COL7A1 FN1 ERO1A NPHP3 CTSK IMPG1 CYP2J2 ADAMTS18 IMPG2 NDNF DDR1 ADAMTSL1 CLASP1 LAMA2 PAPLN ADAMTS13 P4HA1 TLL1 TNR | 9.57e-08 | 377 | 398 | 25 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | THSD4 PDGFRA COL14A1 POMT2 HSPG2 NID2 COL7A1 FN1 ERO1A NPHP3 CTSK IMPG1 CYP2J2 ADAMTS18 IMPG2 NDNF DDR1 ADAMTSL1 CLASP1 LAMA2 PAPLN ADAMTS13 P4HA1 TLL1 TNR | 1.01e-07 | 378 | 398 | 25 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | THSD4 PDGFRA COL14A1 POMT2 HSPG2 NID2 COL7A1 FN1 ERO1A NPHP3 CTSK IMPG1 CYP2J2 ADAMTS18 IMPG2 NDNF DDR1 ADAMTSL1 CLASP1 LAMA2 PAPLN ADAMTS13 P4HA1 TLL1 TNR | 1.06e-07 | 379 | 398 | 25 | GO:0045229 |
| GeneOntologyBiologicalProcess | cell morphogenesis | PRTG MAP1B FAT1 PKHD1 EEF2K MPL PLXNA3 SEMA4F HSPG2 FLNA VLDLR FLNB FN1 SLC39A3 EPB41L5 SPG11 FXN KLF7 MYO16 DHX36 RELN CLSTN3 CDH23 ITGA1 CUL7 SLC30A1 PTK7 IQGAP1 DIP2A PTPRD PTPRM ARHGAP44 VPS13A WDR1 BRWD1 DDR1 ARHGEF28 STXBP5 SLC26A5 LAMA2 SPAG9 LIFR TNR RPL4 CDH8 EPB42 CDH17 | 2.79e-06 | 1194 | 398 | 47 | GO:0000902 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PRTG FAT1 PKD1 CLSTN1 CLSTN3 PCDHA9 CDHR2 CDH23 PTK7 PTPRM FAT4 PCDHGB6 PCDHGA1 CDH8 CDH17 | 3.71e-06 | 187 | 398 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | neuron projection development | EPOR PRTG MAP1B SERPINF1 AP2A1 EEF2K PLXNA3 SEMA4F HSPG2 FLNA VLDLR FN1 GIT1 SPG11 FXN KLF7 MYO16 DHX36 RELN CLSTN3 INPPL1 B2M CDH23 ITGA1 CUL7 SLC30A1 PTK6 PTK7 IQGAP1 DIP2A PTPRD ALMS1 PTPRM ARHGAP44 VPS13A NDNF DDR1 FAT4 DPYSL3 ARHGEF28 STXBP5 LAMA2 SPAG9 LIFR CNTN3 TNR RPL4 | 1.90e-05 | 1285 | 398 | 47 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | PKD1 PKHD1 NID2 ITGA11 FN1 EPB41L5 TRPM7 SIRPA ITGA1 THSD1 ITGA9 IQGAP1 PTPRA DDR1 CLASP1 ADAMTS13 CD36 | 2.15e-05 | 270 | 398 | 17 | GO:0007160 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | EPOR SERPINF1 AP2A1 EEF2K FLNA VLDLR DHX36 RELN SLC30A1 PTK6 PTK7 IQGAP1 PTPRD NDNF DDR1 DPYSL3 | 2.93e-05 | 249 | 398 | 16 | GO:0010976 |
| GeneOntologyBiologicalProcess | neuron development | EPOR PRTG MAP1B SERPINF1 AP2A1 EEF2K PLXNA3 SEMA4F HSPG2 FLNA VLDLR FN1 GIT1 SPG11 FXN KLF7 MYO16 DHX36 RELN CLSTN3 INPPL1 B2M CDH23 ITGA1 CUL7 SLC30A1 PTK6 PTK7 IQGAP1 DIP2A PTPRD ALMS1 PTPRM ARHGAP44 VPS13A NDNF DDR1 FAT4 DPYSL3 DRD1 ARHGEF28 STXBP5 LAMA2 SPAG9 LIFR PALS1 SLC4A10 CNTN3 ROM1 TNR RPL4 | 2.95e-05 | 1463 | 398 | 51 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PRTG MAP1B EEF2K PLXNA3 SEMA4F HSPG2 VLDLR FN1 SPG11 FXN KLF7 MYO16 DHX36 RELN CLSTN3 ITGA1 CUL7 SLC30A1 PTK7 IQGAP1 DIP2A PTPRD PTPRM ARHGAP44 VPS13A DDR1 ARHGEF28 STXBP5 LAMA2 SPAG9 LIFR TNR RPL4 | 3.92e-05 | 802 | 398 | 33 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PRTG MAP1B EEF2K PLXNA3 SEMA4F HSPG2 VLDLR FN1 SPG11 FXN KLF7 MYO16 DHX36 RELN CLSTN3 ITGA1 CUL7 SLC30A1 PTK7 IQGAP1 DIP2A PTPRD PTPRM ARHGAP44 VPS13A DDR1 ARHGEF28 STXBP5 LAMA2 SPAG9 LIFR TNR RPL4 | 5.88e-05 | 819 | 398 | 33 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPOR MAP1B SERPINF1 AP2A1 EEF2K PLXNA3 SEMA4F FLNA VLDLR FN1 FXN DHX36 RELN INPPL1 B2M CUL7 SLC30A1 PTK6 PTK7 IQGAP1 PTPRD ARHGAP44 NDNF DDR1 DPYSL3 TNR RPL4 | 6.35e-05 | 612 | 398 | 27 | GO:0010975 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 STUB1 USP17L1 SOCS6 DYSF PIAS3 ASB10 USP17L4 DCAF13 USP17L24 USP17L5 RNF213 FBXO11 TRIM71 RNF123 USP17L6P OTUD4 USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 CUL7 DCAF5 USP17L18 AREL1 USP17L17 USP17L3 SPSB2 USP17L13 TRIM60 USP17L2 USP17L12 USP17L11 UFL1 USP17L10 USP6 USP17L8 | 6.84e-05 | 1009 | 398 | 38 | GO:0070647 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PRTG MAP1B EEF2K PLXNA3 SEMA4F HSPG2 VLDLR FN1 SPG11 FXN KLF7 MYO16 DHX36 RELN CLSTN3 ITGA1 CUL7 SLC30A1 PTK7 IQGAP1 DIP2A PTPRD PTPRM ARHGAP44 VPS13A DDR1 ARHGEF28 STXBP5 LAMA2 SPAG9 LIFR TNR RPL4 | 6.92e-05 | 826 | 398 | 33 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | EPOR STUB1 MAP1B PDGFRB SERPINF1 AP2A1 SNX7 EEF2K PLXNA3 FLNA VLDLR FN1 GIT1 PPM1E EPB41L5 FXN CLSTN1 RAB3GAP1 DHX36 RELN CLSTN3 CYP2J2 B2M SIRPA CUL7 GDF2 SLC30A1 PTK6 PTK7 IQGAP1 PTPRD ALMS1 PAN2 WDR1 MLST8 CACNA1B NDNF DDR1 DPYSL3 CLASP1 UFL1 TFR2 VPS13D CD36 LRP5 RPL4 CDH17 | 8.51e-05 | 1366 | 398 | 47 | GO:0051130 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 ABCA2 STUB1 USP17L1 SOCS6 DYSF PIAS3 ASB10 USP17L4 DCAF13 USP17L24 USP17L5 RNF213 FBXO11 TRIM71 RNF123 USP17L6P OTUD4 USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 CUL7 DCAF5 USP17L18 AREL1 USP17L17 USP17L3 SPSB2 USP17L13 TRIM60 USP17L2 USP17L12 USP17L11 UFL1 USP17L10 USP6 USP17L8 | 1.18e-04 | 1074 | 398 | 39 | GO:0043687 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PRTG FAT1 PKD1 SPARCL1 CLSTN1 CLSTN3 PCDHA9 CDHR2 CDH23 PTK7 PTPRD PTPRM FAT4 PCDHGB6 PCDHGA1 CDH8 CDH17 | 1.35e-04 | 313 | 398 | 17 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | PKD1 PKHD1 FNDC3B NID2 FLNA ITGA11 FN1 EPB41L5 TRPM7 SIRPA ITGA1 THSD1 ITGA9 IQGAP1 PTPRA NDNF DDR1 CLASP1 ADAMTS13 CD36 | 1.53e-04 | 410 | 398 | 20 | GO:0031589 |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 1.89e-04 | 44 | 398 | 6 | GO:0001736 | |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 2.14e-04 | 45 | 398 | 6 | GO:0007164 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L7 USP17L1 PDGFRA WDR81 EXT2 ERMP1 HMOX1 MSMO1 SLC35D3 SUCO SEC61A1 POMT2 USP17L4 ERO1A USP17L5 CLSTN1 NBAS RAB3GAP1 ERGIC3 CYP2R1 USP17L6P USP17L22 ADPGK USP17L15 USP17L21 CLSTN3 EMC7 CYP2J2 ERAP1 USP17L20 B2M USP17L19 ITPR2 USP17L18 LPCAT2 USP17L17 VPS13A USP17L3 USP17L13 TMED1 DRD1 USP17L2 RHBDF1 USP17L12 USP17L11 UFL1 USP17L10 DOLPP1 LRBA USP17L8 | 2.64e-06 | 1293 | 406 | 50 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L7 USP17L1 PDGFRA WDR81 EXT2 ERMP1 HMOX1 MSMO1 SLC35D3 SUCO SEC61A1 POMT2 USP17L4 ERO1A USP17L5 CLSTN1 NBAS RAB3GAP1 ERGIC3 CYP2R1 USP17L6P USP17L22 ADPGK USP17L15 USP17L21 CLSTN3 EMC7 CYP2J2 ERAP1 USP17L20 B2M USP17L19 ITPR2 USP17L18 LPCAT2 USP17L17 VPS13A USP17L3 USP17L13 TMED1 DRD1 USP17L2 RHBDF1 USP17L12 USP17L11 UFL1 USP17L10 DOLPP1 LRBA USP17L8 | 3.00e-06 | 1299 | 406 | 50 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L7 USP17L1 PDGFRA WDR81 EXT2 ERMP1 HMOX1 MSMO1 SLC35D3 SUCO SEC61A1 POMT2 USP17L4 ERO1A USP17L5 CLSTN1 NBAS RAB3GAP1 ERGIC3 CYP2R1 USP17L6P USP17L22 ADPGK USP17L15 USP17L21 CLSTN3 EMC7 CYP2J2 ERAP1 USP17L20 B2M USP17L19 ITPR2 USP17L18 LPCAT2 USP17L17 VPS13A USP17L3 USP17L13 TMED1 DRD1 USP17L2 RHBDF1 USP17L12 USP17L11 UFL1 USP17L10 DOLPP1 LRBA USP17L8 | 5.43e-06 | 1327 | 406 | 50 | GO:0042175 |
| GeneOntologyCellularComponent | cell surface | EPOR PDGFRA PDGFRB ENPP3 TRPC4 CEACAM21 LY6G6D PKD1 PKHD1 ABCC2 MPL NID2 VLDLR ITGA11 CLSTN1 SIGLEC7 VCAN BTN2A3P LAMP3 ASTN1 CTSK CLSTN3 ADAM20 B2M SIRPA ITGA1 THSD1 ITGA9 DIP2A DPP6 DRD1 APMAP MUC16 ADAMTS13 TFR2 LIFR CD36 RORC HTR3B TNR CDH17 | 6.42e-05 | 1111 | 406 | 41 | GO:0009986 |
| GeneOntologyCellularComponent | mCRD-mediated mRNA stability complex | 1.39e-04 | 6 | 406 | 3 | GO:0106002 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 1.39e-04 | 6 | 406 | 3 | GO:0033165 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MAOB MAP1B SERPINF1 PIAS3 SORCS2 EEF2K TXN2 CNGA2 SYNCRIP MPL SEMA4F FLNA FLNB GIT1 ERO1A SPG11 TXNRD2 CLSTN1 PABPC1 ASTN1 DHX36 RELN BRINP3 CLSTN3 TRPM7 INPP5A ITGA1 SLC30A1 PTK7 DIP2A ARHGAP44 KCNJ14 VPS13A ASTN2 CACNA1B DPP6 DRD1 LAMA2 PALS1 PABPC3 SLC4A10 HTR3B | 2.71e-04 | 1228 | 406 | 42 | GO:0036477 |
| GeneOntologyCellularComponent | focal adhesion | PDGFRB FAT1 HSPG2 FLNA FLNB ITGA11 GIT1 EPB41L5 PABPC1 XIRP2 B2M ITGA1 THSD1 PTK7 IQGAP1 PTPRA CLASP1 CAT ALKBH6 RPL4 | 3.21e-04 | 431 | 406 | 20 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | PDGFRB FAT1 HSPG2 FLNA FLNB ITGA11 GIT1 EPB41L5 PABPC1 XIRP2 B2M ITGA1 THSD1 PTK7 IQGAP1 PTPRA CLASP1 CAT ALKBH6 RPL4 | 4.56e-04 | 443 | 406 | 20 | GO:0030055 |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 6.19e-04 | 36 | 406 | 5 | GO:0098992 | |
| GeneOntologyCellularComponent | basement membrane | 6.36e-04 | 122 | 406 | 9 | GO:0005604 | |
| HumanPheno | Tibial bowing | 5.40e-06 | 41 | 126 | 8 | HP:0002982 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L24 USP17L5 USP17L22 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 | 3.29e-22 | 16 | 395 | 14 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L24 USP17L5 USP17L22 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 | 3.29e-22 | 16 | 395 | 14 | IPR006861 |
| Domain | UCH | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L22 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 1.67e-17 | 71 | 395 | 20 | PF00443 |
| Domain | USP_dom | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L22 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 2.27e-17 | 72 | 395 | 20 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L22 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 2.27e-17 | 72 | 395 | 20 | IPR001394 |
| Domain | USP_3 | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L22 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 2.27e-17 | 72 | 395 | 20 | PS50235 |
| Domain | USP_2 | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L22 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 3.12e-16 | 71 | 395 | 19 | PS00973 |
| Domain | USP_CS | USP17L7 USP17L1 USP17L24 USP17L5 USP17L22 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 1.32e-15 | 66 | 395 | 18 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L4 USP17L24 USP17L5 USP17L22 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP6 USP17L8 | 4.14e-15 | 70 | 395 | 18 | PS00972 |
| Domain | - | EPOR PRTG PDGFRA PDGFRB CEACAM21 PKHD1 COL14A1 MPL PLXNA3 FNDC3B HSPG2 FLNA FLNB COL7A1 FN1 TRIM71 SIGLEC7 VCAN ASTN1 POGLUT3 B2M SIRPA PTK7 AREL1 PTPRB PTPRD PTPRM SIGLEC10 ASTN2 NDNF ADAMTSL1 PAPLN LIFR CNTN3 TNR ALPK2 EPB42 | 8.28e-08 | 663 | 395 | 37 | 2.60.40.10 |
| Domain | Ig-like_fold | EPOR PRTG PDGFRA PDGFRB CEACAM21 PKHD1 COL14A1 MPL PLXNA3 FNDC3B HSPG2 FLNA FLNB COL7A1 FN1 TRIM71 SIGLEC7 VCAN BTN2A3P ASTN1 POGLUT3 B2M SIRPA PTK7 AREL1 PTPRB PTPRD PTPRM SIGLEC10 ASTN2 NDNF ADAMTSL1 PAPLN LIFR CNTN3 TNR ALPK2 EPB42 | 1.39e-07 | 706 | 395 | 38 | IPR013783 |
| Domain | IG_FLMN | 9.53e-07 | 10 | 395 | 5 | SM00557 | |
| Domain | Cadherin | FAT1 CLSTN1 CLSTN3 PCDHA9 CDHR2 CDH23 FREM2 FAT4 PCDHGB6 PCDHGA1 FREM3 CDH8 CDH17 | 1.30e-06 | 118 | 395 | 13 | IPR002126 |
| Domain | Filamin | 1.72e-06 | 11 | 395 | 5 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.72e-06 | 11 | 395 | 5 | PS50194 | |
| Domain | Filamin/ABP280_repeat-like | 1.72e-06 | 11 | 395 | 5 | IPR017868 | |
| Domain | Filamin/ABP280_rpt | 1.72e-06 | 11 | 395 | 5 | IPR001298 | |
| Domain | FN3 | EPOR PRTG COL14A1 MPL FNDC3B COL7A1 FN1 ASTN1 PTPRB PTPRD PTPRM ASTN2 NDNF LIFR CNTN3 TNR | 2.11e-06 | 185 | 395 | 16 | SM00060 |
| Domain | FN3 | EPOR PRTG COL14A1 MPL FNDC3B COL7A1 FN1 ASTN1 PTPRB PTPRD PTPRM ASTN2 NDNF LIFR CNTN3 TNR | 5.44e-06 | 199 | 395 | 16 | PS50853 |
| Domain | CA | FAT1 CLSTN1 CLSTN3 PCDHA9 CDHR2 CDH23 FREM2 FAT4 PCDHGB6 PCDHGA1 CDH8 CDH17 | 5.88e-06 | 115 | 395 | 12 | SM00112 |
| Domain | FN3_dom | EPOR PRTG COL14A1 MPL FNDC3B COL7A1 FN1 ASTN1 PTPRB PTPRD PTPRM ASTN2 NDNF LIFR CNTN3 TNR | 1.01e-05 | 209 | 395 | 16 | IPR003961 |
| Domain | EGF-like_dom | FAT1 HSPG2 NID2 VLDLR ZAN VCAN ASTN1 RELN IMPG1 ADAM20 STAB1 IMPG2 FAT4 LAMA2 TLL1 LRP5 TNR | 2.41e-05 | 249 | 395 | 17 | IPR000742 |
| Domain | CADHERIN_1 | FAT1 CLSTN1 CLSTN3 PCDHA9 CDHR2 CDH23 FAT4 PCDHGB6 PCDHGA1 CDH8 CDH17 | 2.78e-05 | 113 | 395 | 11 | PS00232 |
| Domain | Cadherin | FAT1 CLSTN1 CLSTN3 PCDHA9 CDHR2 CDH23 FAT4 PCDHGB6 PCDHGA1 CDH8 CDH17 | 2.78e-05 | 113 | 395 | 11 | PF00028 |
| Domain | - | FAT1 CLSTN1 CLSTN3 PCDHA9 CDHR2 CDH23 FAT4 PCDHGB6 PCDHGA1 CDH8 CDH17 | 3.02e-05 | 114 | 395 | 11 | 2.60.40.60 |
| Domain | CADHERIN_2 | FAT1 CLSTN1 CLSTN3 PCDHA9 CDHR2 CDH23 FAT4 PCDHGB6 PCDHGA1 CDH8 CDH17 | 3.02e-05 | 114 | 395 | 11 | PS50268 |
| Domain | EGF_1 | FAT1 HSPG2 VLDLR FN1 ZAN VCAN ASTN1 RELN ADAM20 STAB1 ASTN2 IMPG2 FAT4 LAMA2 TLL1 LRP5 TNR | 3.26e-05 | 255 | 395 | 17 | PS00022 |
| Domain | Cadherin-like | FAT1 CLSTN1 CLSTN3 PCDHA9 CDHR2 CDH23 FAT4 PCDHGB6 PCDHGA1 CDH8 CDH17 | 3.55e-05 | 116 | 395 | 11 | IPR015919 |
| Domain | fn3 | EPOR PRTG COL14A1 MPL FNDC3B COL7A1 FN1 PTPRB PTPRD PTPRM LIFR CNTN3 TNR | 4.20e-05 | 162 | 395 | 13 | PF00041 |
| Domain | EGF_3 | FAT1 HSPG2 NID2 VLDLR ZAN VCAN ASTN1 RELN ADAM20 STAB1 ASTN2 IMPG2 FAT4 TLL1 LRP5 TNR | 4.30e-05 | 235 | 395 | 16 | PS50026 |
| Domain | EGF-like_CS | FAT1 HSPG2 NID2 VLDLR FN1 ZAN VCAN ASTN1 RELN ADAM20 STAB1 IMPG2 FAT4 LAMA2 TLL1 LRP5 TNR | 4.37e-05 | 261 | 395 | 17 | IPR013032 |
| Domain | EGF_2 | FAT1 HSPG2 NID2 VLDLR ZAN VCAN ASTN1 RELN ADAM20 STAB1 ASTN2 IMPG2 FAT4 LAMA2 TLL1 LRP5 TNR | 5.28e-05 | 265 | 395 | 17 | PS01186 |
| Domain | ConA-like_dom | ADGRG4 FAT1 COL14A1 HSPG2 ZAN CLSTN1 RNF123 CLSTN3 PTPRM COL21A1 SPSB2 TRIM60 FAT4 LAMA2 LRBA | 6.94e-05 | 219 | 395 | 15 | IPR013320 |
| Domain | PolyA | 9.10e-05 | 5 | 395 | 3 | SM00517 | |
| Domain | PABP | 9.10e-05 | 5 | 395 | 3 | PF00658 | |
| Domain | PABC | 9.10e-05 | 5 | 395 | 3 | PS51309 | |
| Domain | - | 9.10e-05 | 5 | 395 | 3 | 1.10.1900.10 | |
| Domain | PABP_1234 | 9.10e-05 | 5 | 395 | 3 | IPR006515 | |
| Domain | PABP_HYD | 9.10e-05 | 5 | 395 | 3 | IPR002004 | |
| Domain | - | WDR81 PLRG1 PLXNA3 SEMA4F DCAF13 STXBP5L NBAS DCAF5 DMXL1 PAN2 WDR1 MLST8 BRWD1 WDR7 STXBP5 SPAG9 KCTD3 LRBA HPS5 | 9.45e-05 | 333 | 395 | 19 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | WDR81 PLRG1 PLXNA3 SEMA4F DCAF13 STXBP5L NBAS DCAF5 DMXL1 PAN2 WDR1 MLST8 BRWD1 WDR7 STXBP5 SPAG9 KCTD3 LRBA HPS5 | 1.02e-04 | 335 | 395 | 19 | IPR015943 |
| Domain | EGF | FAT1 HSPG2 NID2 VLDLR ZAN VCAN ASTN1 RELN BRINP3 STAB1 FAT4 LAMA2 TLL1 LRP5 TNR | 1.52e-04 | 235 | 395 | 15 | SM00181 |
| Domain | PLAC | 1.67e-04 | 14 | 395 | 4 | PF08686 | |
| Domain | SEA | 1.67e-04 | 14 | 395 | 4 | SM00200 | |
| Domain | VWA | 1.70e-04 | 56 | 395 | 7 | PF00092 | |
| Domain | Alpha_kinase | 1.79e-04 | 6 | 395 | 3 | PF02816 | |
| Domain | MHCK_EF2_kinase | 1.79e-04 | 6 | 395 | 3 | IPR004166 | |
| Domain | Alpha_kinase | 1.79e-04 | 6 | 395 | 3 | SM00811 | |
| Domain | ALPHA_KINASE | 1.79e-04 | 6 | 395 | 3 | PS51158 | |
| Domain | - | 1.83e-04 | 95 | 395 | 9 | 2.60.120.200 | |
| Domain | WD40_repeat_dom | WDR81 PLRG1 DCAF13 STXBP5L DCAF5 DMXL1 PAN2 WDR1 MLST8 BRWD1 WDR7 STXBP5 SPAG9 LRRK1 KCTD3 LRBA HPS5 | 2.11e-04 | 297 | 395 | 17 | IPR017986 |
| Domain | Ig_I-set | PRTG PDGFRA PDGFRB CEACAM21 HSPG2 SIGLEC7 PTK7 PTPRD SIGLEC10 ADAMTSL1 PAPLN CNTN3 ALPK2 | 2.11e-04 | 190 | 395 | 13 | IPR013098 |
| Domain | I-set | PRTG PDGFRA PDGFRB CEACAM21 HSPG2 SIGLEC7 PTK7 PTPRD SIGLEC10 ADAMTSL1 PAPLN CNTN3 ALPK2 | 2.11e-04 | 190 | 395 | 13 | PF07679 |
| Domain | Ig_E-set | 3.62e-04 | 104 | 395 | 9 | IPR014756 | |
| Domain | Lgl_C | 4.46e-04 | 2 | 395 | 2 | PF08596 | |
| Domain | Astrotactin | 4.46e-04 | 2 | 395 | 2 | IPR026995 | |
| Domain | Lgl_C_dom | 4.46e-04 | 2 | 395 | 2 | IPR013905 | |
| Domain | Cadherin_CS | 5.12e-04 | 109 | 395 | 9 | IPR020894 | |
| Domain | PLAC | 5.94e-04 | 19 | 395 | 4 | PS50900 | |
| Domain | PLAC | 5.94e-04 | 19 | 395 | 4 | IPR010909 | |
| Domain | DNA-bd_RFX | 7.17e-04 | 9 | 395 | 3 | IPR003150 | |
| Domain | RFX_DNA_binding | 7.17e-04 | 9 | 395 | 3 | PF02257 | |
| Domain | RFX_DBD | 7.17e-04 | 9 | 395 | 3 | PS51526 | |
| Domain | MAGE_N | 7.30e-04 | 20 | 395 | 4 | SM01392 | |
| Domain | FG_GAP | 1.07e-03 | 22 | 395 | 4 | PS51470 | |
| Domain | MAGE_N | 1.07e-03 | 22 | 395 | 4 | IPR021072 | |
| Domain | MAGE_N | 1.07e-03 | 22 | 395 | 4 | PF12440 | |
| Domain | SEA | 1.07e-03 | 22 | 395 | 4 | PF01390 | |
| Domain | SEA | 1.27e-03 | 23 | 395 | 4 | PS50024 | |
| Domain | SEA_dom | 1.27e-03 | 23 | 395 | 4 | IPR000082 | |
| Domain | EGF-like_Ca-bd_dom | 1.29e-03 | 124 | 395 | 9 | IPR001881 | |
| Domain | - | 1.31e-03 | 39 | 395 | 5 | 2.120.10.30 | |
| Domain | RFX1_trans_act | 1.32e-03 | 3 | 395 | 2 | IPR007668 | |
| Domain | RFX1_trans_act | 1.32e-03 | 3 | 395 | 2 | PF04589 | |
| Domain | VPS13_N2 | 1.32e-03 | 3 | 395 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.32e-03 | 3 | 395 | 2 | IPR031642 | |
| Domain | Calsyntenin | 1.32e-03 | 3 | 395 | 2 | IPR026914 | |
| Domain | VPS13 | 1.32e-03 | 3 | 395 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.32e-03 | 3 | 395 | 2 | PF16910 | |
| Domain | VPS13 | 1.32e-03 | 3 | 395 | 2 | PF16908 | |
| Domain | Laminin_G | 1.38e-03 | 58 | 395 | 6 | IPR001791 | |
| Domain | EGF | 1.45e-03 | 126 | 395 | 9 | PF00008 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.50e-03 | 24 | 395 | 4 | IPR013273 | |
| Domain | FG-GAP | 1.50e-03 | 24 | 395 | 4 | PF01839 | |
| Domain | FG-GAP | 1.50e-03 | 24 | 395 | 4 | IPR013517 | |
| Domain | IGc2 | PRTG PDGFRA PDGFRB CEACAM21 HSPG2 SIGLEC7 PTK7 PTPRD SIGLEC10 ADAMTSL1 PAPLN CNTN3 ALPK2 | 1.55e-03 | 235 | 395 | 13 | SM00408 |
| Domain | Ig_sub2 | PRTG PDGFRA PDGFRB CEACAM21 HSPG2 SIGLEC7 PTK7 PTPRD SIGLEC10 ADAMTSL1 PAPLN CNTN3 ALPK2 | 1.55e-03 | 235 | 395 | 13 | IPR003598 |
| Domain | VWFA | 1.75e-03 | 82 | 395 | 7 | PS50234 | |
| Domain | MACPF | 1.79e-03 | 12 | 395 | 3 | SM00457 | |
| Domain | MACPF | 1.79e-03 | 12 | 395 | 3 | IPR020864 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 8.54e-21 | 45 | 292 | 19 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L1 USP17L4 USP17L5 RNF123 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 PSMB4 PSMD7 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 6.85e-11 | 191 | 292 | 22 | MM15289 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L1 PDGFRA PDGFRB FGF6 USP17L4 FN1 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 PSMB4 PSMD7 USP17L19 IQGAP1 USP17L18 PTPRA USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 5.20e-10 | 318 | 292 | 27 | MM15278 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L1 USP17L4 USP17L24 USP17L5 RNF123 USP17L22 USP17L15 USP17L21 USP17L20 PSMB4 PSMD7 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 6.47e-09 | 221 | 292 | 21 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L1 USP17L4 USP17L5 RNF123 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 PSMB4 PSMD7 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.72e-08 | 262 | 292 | 22 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L1 USP17L4 USP17L24 USP17L5 RNF123 USP17L22 USP17L15 USP17L21 USP17L20 PSMB4 PSMD7 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.12e-06 | 299 | 292 | 21 | M27574 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A5 COL14A1 HSPG2 NID2 COL7A1 ITGA11 FN1 VCAN CTSK ITGA1 ITGA9 COL21A1 ADAMTS18 DDR1 LAMA2 P4HA1 TLL1 TNR | 5.50e-05 | 300 | 292 | 18 | M610 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.86e-05 | 84 | 292 | 9 | M7098 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 7.75e-05 | 68 | 292 | 8 | M27303 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 9.13e-05 | 23 | 292 | 5 | M47720 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | THSD4 EXT2 POMT2 HSPG2 VCAN THSD1 ADAMTS18 ADAMTSL1 MUC16 ADAMTS13 LFNG | 1.91e-04 | 143 | 292 | 11 | M27275 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.80e-35 | 21 | 408 | 19 | 8622927 |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.80e-35 | 21 | 408 | 19 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.80e-35 | 21 | 408 | 19 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.80e-35 | 21 | 408 | 19 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.80e-35 | 21 | 408 | 19 | 12447969 |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.80e-35 | 21 | 408 | 19 | 18980247 | |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.03e-34 | 22 | 408 | 19 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 5.50e-33 | 24 | 408 | 19 | 8995226 |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.27e-32 | 25 | 408 | 19 | 21115691 | |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 8.33e-32 | 26 | 408 | 19 | 35816173 | |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 7.61e-31 | 33 | 408 | 20 | 20228807 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 15780755 |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 17109758 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 9806828 |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 19188362 |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 11941478 | |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 20388806 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 20368735 |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 10936051 | |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.83e-30 | 34 | 408 | 20 | 21448158 | |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.46e-30 | 29 | 408 | 19 | 32527007 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 4.22e-30 | 35 | 408 | 20 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 4.22e-30 | 35 | 408 | 20 | 21239494 |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 9.40e-30 | 36 | 408 | 20 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.02e-29 | 37 | 408 | 20 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L1 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 2.98e-24 | 50 | 408 | 19 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | USP17L7 USP17L1 USP17L4 USP17L6P USP17L15 USP17L3 USP17L2 USP17L8 | 1.48e-14 | 10 | 408 | 8 | 24207026 |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L6P USP17L15 USP17L3 USP17L2 USP17L8 | 1.59e-13 | 12 | 408 | 8 | 24695638 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCA2 MAP1B CNPY4 SPC25 EXT2 ERMP1 HMOX1 FANCA FAT1 MSMO1 PLEKHA5 SUCO SEC61A1 POMT2 PLXNA3 HSPG2 COL7A1 ITGA11 ERO1A RNF213 CPD CLSTN1 ERGIC3 ADPGK DHX36 CLSTN3 EMC7 ERAP1 ITGA1 SLC30A1 DMXL1 PTK7 ITFG1 ITPR2 LPCAT2 TTC13 CHPF TMED1 CACNA2D1 FAT4 DPYSL3 DOLPP1 LIFR P4HA1 TLL1 FAM3A LRP5 | 6.45e-13 | 1201 | 408 | 47 | 35696571 |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L7 USP17L1 USP17L4 USP17L6P USP17L15 USP17L3 USP17L2 USP17L8 | 9.46e-13 | 14 | 408 | 8 | 11793228 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L7 USP17L1 USP17L4 USP17L6P USP17L15 USP17L3 USP17L2 USP17L8 | 2.26e-11 | 19 | 408 | 8 | 28067227 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | STUB1 PDGFRA SLC39A9 PDGFRB CNPY4 MRPS35 MCM7 EXT2 HMOX1 GUF1 FAT1 MSMO1 SEC61A1 ACBD3 SYNCRIP POMT2 FNDC3B HSPG2 NID2 FLNA FLNB FN1 ERO1A RNF213 CPD CLSTN1 PABPC1 ERGIC3 ADPGK POGLUT3 EMC7 IMPG1 ERAP1 B2M ITGA1 SLC30A1 DCAF5 PTK7 IQGAP1 DNAH6 TMED1 CPSF6 CAT CBR4 P4HA1 PABPC3 RPL4 | 3.94e-10 | 1451 | 408 | 47 | 30550785 |
| Pubmed | ABCA2 PDGFRA PDGFRB ACOX1 PEX14 MCM7 EXT2 ERMP1 AP2A1 TUBGCP3 PLEKHA5 ACBD3 SYNCRIP FLNA GIT1 ERO1A RNF213 CPD ENPP4 PABPC1 NBAS ERGIC3 CHTF18 MARF1 ADPGK ERAP1 B2M PSMD7 ITGA1 ITPR2 EXOC7 CLASP1 CPSF6 APMAP CAT ASPHD2 HEATR1 ECH1 P4HA1 LRBA RPL4 | 5.60e-10 | 1168 | 408 | 41 | 19946888 | |
| Pubmed | USP17L7 USP17L1 USP17L4 USP17L6P USP17L15 ADAM20 PAN2 USP17L3 USP17L2 USP6 USP17L8 | 2.94e-09 | 81 | 408 | 11 | 12838346 | |
| Pubmed | USP17L7 MAGEA11 USP17L1 CEACAM21 SORCS2 SPARCL1 USP17L4 ZAN USP17L5 BTN2A3P USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 DPP6 USP17L2 USP17L12 USP17L11 USP17L10 PLA2G4E IRAK3 USP17L8 | 1.04e-08 | 674 | 408 | 28 | 37196079 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | STUB1 AGL PKD1 DCTPP1 SUCO POMT2 DNAJC4 GIT1 EPB41L5 CPD PABPC1 ERGIC3 INTS13 CHTF18 ABTB1 ADPGK DHX36 CLSTN3 RAPGEF6 DIP2A BRD8 WDR1 MLST8 EXOC7 BRWD1 ARHGEF28 CPSF6 SPAG9 USP6 BRF1 AASS FAM3A RPL4 | 2.00e-08 | 925 | 408 | 33 | 28986522 |
| Pubmed | 6.00e-08 | 64 | 408 | 9 | 22261194 | ||
| Pubmed | STUB1 MRPS35 EXT2 GUF1 TUBGCP3 PLEKHA5 COL14A1 EEF2K SUCO SEC61A1 ACBD3 PLRG1 SYNCRIP DNAJC4 DCAF13 ANK2 ERO1A EPB41L5 SPG11 CPD NBAS RAB3GAP1 POGLUT3 EMC7 TRPM7 PSMD7 SLC30A1 DCAF5 DMXL1 PTK7 ITPR2 DIP2A PMPCA SUPT6H VPS13A TTC13 RALGAPB UFL1 HEATR1 ECH1 LIFR P4HA1 RPL4 | 6.09e-08 | 1487 | 408 | 43 | 33957083 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | STUB1 FBL MRPS35 PEX14 GUF1 SUCO SEC61A1 ACBD3 DDX4 SYNCRIP TOM1L2 RNF213 CPD ZDBF2 NUDT16L1 NBAS RAB3GAP1 DHX36 EMC7 TRPM7 MTHFD2 PSMB4 PSMD7 CUL7 ITPR2 DIP2A ALMS1 PMPCA VPS13A TTC13 RMND1 PRRC2B CPSF6 CAT UFL1 SPAG9 HEATR1 LARS2 ECH1 VPS13D AASS PTAR1 RPL4 | 7.20e-08 | 1496 | 408 | 43 | 32877691 |
| Pubmed | MAP1B FANCA TUBGCP3 PLEKHA5 SEC61A1 PLRG1 FNDC3B CLSTN1 PLCD3 CHTF18 MARF1 DHX36 RAPGEF6 PTK7 FREM2 DIP2A EXOC7 PRRC2B ARHGEF28 RALGAPB PAPLN ANKRD50 PALS1 TLL1 HPS5 CWF19L1 | 7.43e-08 | 650 | 408 | 26 | 38777146 | |
| Pubmed | USP17L7 USP17L1 COL14A1 USP17L4 USP17L3 HGSNAT CSMD1 USP17L8 | 8.39e-08 | 48 | 408 | 8 | 16421571 | |
| Pubmed | PLEKHH2 EPB41L5 RNF213 ZNF407 ENPP4 CLSTN1 PLCD3 RAB3GAP1 NPHP3 DNAH17 DOP1A TCAF1 CUL7 TNRC18 PER3 ALMS1 ASTN2 EXOC7 ARHGEF28 SPAG9 SLC45A4 VPS13D | 1.19e-07 | 493 | 408 | 22 | 15368895 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 ZNF585A DYSF FANCA FAT1 AP2A1 PKD1 PLXNA3 SEMA4F HSPG2 FLNA TXNRD2 PLCD3 MROH6 HMGXB3 MYBL2 RAPGEF6 INPPL1 DGKQ ITPR2 DIP2A BMP8B TNRC18 ARHGAP44 POLL CHPF PRRC2B RHBDF1 PAPLN LRRK1 LARS2 MROH1 LRP5 LRBA ALKBH6 | 1.34e-07 | 1105 | 408 | 35 | 35748872 |
| Pubmed | SOCS6 DYSF AGL TUBGCP3 COL14A1 FNDC3B HSPG2 FLNB ZFAT FN1 ANK2 GIT1 ZNF407 NPHP3 XIRP2 ABLIM2 ADPGK ALMS1 SUPT6H LAMA2 ANKRD50 P4HA1 | 1.37e-07 | 497 | 408 | 22 | 23414517 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | STUB1 MRPS35 EXT2 AP2A1 AGL DCTPP1 SEC61A1 ACBD3 SYNCRIP FLNA FLNB ERO1A EPB41L5 CPD PSMB4 PSMD7 PTK7 PTPRA PTPRD PMPCA PTPRM TTC13 WDR1 RMND1 PRRC2B TMED1 CLASP1 SPAG9 HEATR1 ANKRD50 KCTD3 RPL4 | 2.12e-07 | 974 | 408 | 32 | 28675297 |
| Pubmed | ABCA2 STUB1 PDGFRB MRPS35 PLEKHH1 GUF1 AP2A1 PIAS3 PKD1 SPARCL1 ACBD3 VLDLR FLNB FN1 ANK2 GIT1 FBXO11 RNF123 ASTN1 RELN CLSTN3 TRPM7 PSMB4 PSMD7 SYNC DCAF5 IQGAP1 STAB1 DIP2A PTPRA PTPRD ASTN2 MLST8 EXOC7 CHPF BRWD1 LRBA ALKBH6 | 2.16e-07 | 1285 | 408 | 38 | 35914814 | |
| Pubmed | SERPINF1 SPARCL1 HSPG2 FN1 SIRPA ITGA1 FREM2 PTPRM VNN2 CNDP1 CACNA2D1 APMAP LAMA2 ADAMTS13 CNTN3 | 4.60e-07 | 257 | 408 | 15 | 16335952 | |
| Pubmed | EFCAB5 ACACB MAP1B MRPS35 TKTL1 AP2A1 PKHD1 CC2D2A ABCC2 SEC61A1 SYNCRIP PLXNA3 FLNA FLNB DCAF13 ANK2 SPG11 PABPC1 CNKSR3 MARF1 PABPC1L DOP1A PRELID1 PSMD7 PTK7 IQGAP1 TNRC18 PMPCA VPS13A DNAH6 PRRC2B PCDHGB6 PCDHGA1 CAT HEATR1 PABPC3 IRAK3 PADI6 LRMDA RPL4 | 5.25e-07 | 1442 | 408 | 40 | 35575683 | |
| Pubmed | 9.50e-07 | 29 | 408 | 6 | 22613833 | ||
| Pubmed | 1.60e-06 | 3 | 408 | 3 | 26134869 | ||
| Pubmed | 1.60e-06 | 3 | 408 | 3 | 25034140 | ||
| Pubmed | 1.60e-06 | 3 | 408 | 3 | 36514952 | ||
| Pubmed | Epab and Pabpc1 are differentially expressed in the postnatal mouse ovaries. | 1.60e-06 | 3 | 408 | 3 | 25370180 | |
| Pubmed | 1.60e-06 | 3 | 408 | 3 | 26843391 | ||
| Pubmed | Epab and Pabpc1 are differentially expressed during male germ cell development. | 1.60e-06 | 3 | 408 | 3 | 22814100 | |
| Pubmed | Epab is dispensable for mouse spermatogenesis and male fertility. | 1.60e-06 | 3 | 408 | 3 | 24599567 | |
| Pubmed | 1.60e-06 | 3 | 408 | 3 | 26766421 | ||
| Pubmed | 1.60e-06 | 3 | 408 | 3 | 24022915 | ||
| Pubmed | THSD4 FBL AP2A1 PLXNA3 HSPG2 FLNA FN1 RNF213 RNF123 ABTB1 CUL7 LRP5 RPL4 | 1.72e-06 | 214 | 408 | 13 | 22199357 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | THSD4 MAP1B FBL SEC61A1 SYNCRIP HSPG2 NID2 FLNA FLNB FN1 VCAN FREM2 CPSF6 | 2.22e-06 | 219 | 408 | 13 | 31353912 |
| Pubmed | 2.24e-06 | 9 | 408 | 4 | 28203794 | ||
| Pubmed | Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners. | 2.24e-06 | 9 | 408 | 4 | 22952693 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 2.86e-06 | 100 | 408 | 9 | 25807483 | |
| Pubmed | ACACB ZFYVE9 AP2A1 PLEKHA5 ACBD3 EPB41L5 CPD RAPGEF6 INPPL1 SLC30A1 PTK7 PTPRM RALGAPB UFL1 ANKRD50 ECH1 PALS1 LRBA | 3.08e-06 | 421 | 408 | 18 | 36976175 | |
| Pubmed | 3.78e-06 | 21 | 408 | 5 | 27856617 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | SERPINF1 COL6A5 COL14A1 HSPG2 NID2 COL7A1 FN1 VCAN COL21A1 LAMA2 | 4.74e-06 | 135 | 408 | 10 | 28675934 |
| Pubmed | 5.02e-06 | 107 | 408 | 9 | 11347906 | ||
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 6.36e-06 | 4 | 408 | 3 | 22984479 | |
| Pubmed | 6.36e-06 | 4 | 408 | 3 | 10521804 | ||
| Pubmed | 6.36e-06 | 4 | 408 | 3 | 11739414 | ||
| Pubmed | 6.36e-06 | 4 | 408 | 3 | 8843393 | ||
| Pubmed | 6.36e-06 | 4 | 408 | 3 | 15630085 | ||
| Pubmed | Amino- and carboxyl-terminal domains of Filamin-A interact with CRMP1 to mediate Sema3A signalling. | 6.36e-06 | 4 | 408 | 3 | 25358863 | |
| Pubmed | 6.88e-06 | 40 | 408 | 6 | 16210410 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | USP17L7 FANCA AGL PKD1 PKHD1 SEMA4F FLNB FN1 RNF213 RNF123 SYNC PHF8 ITPR2 FREM2 DIP2A DQX1 CEP95 VPS13A USP17L3 FAT4 USP17L12 SPAG9 P4HA1 TNR | 8.15e-06 | 736 | 408 | 24 | 29676528 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACB BEND4 DYSF PLEKHA5 PLRG1 FN1 SPG11 XIRP2 HYDIN NAT9 PSMD7 DIP2A PTPRB RMND1 CLASP1 CPSF6 VPS13D P4HA1 LRBA | 8.18e-06 | 497 | 408 | 19 | 36774506 |
| Pubmed | PDGFRB FAT1 HSPG2 FLNA FLNB ITGA11 GIT1 PABPC1 B2M ITGA1 PTK7 IQGAP1 CAT RPL4 | 8.19e-06 | 285 | 408 | 14 | 21423176 | |
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | STUB1 MSMO1 SYNCRIP ZFAT ZNF407 TXNRD2 PABPC1 ANKS3 MYBL2 ERAP1 B2M IRF1 VPS13A HEATR1 PALS1 AASS PABPC3 PTAR1 | 9.46e-06 | 457 | 408 | 18 | 32968282 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FBL ENPP3 SERPINF1 DYSF FAT1 PKD1 PKHD1 TOM1L2 HSPG2 FLNA FLNB FN1 PM20D1 ENPP4 RAB3GAP1 SLC12A3 ACOT11 CDHR2 B2M PBLD SIRPA ITGA1 GDF2 IQGAP1 WDR1 CACNA2D1 SPAG9 PALS1 VPS13D | 1.20e-05 | 1016 | 408 | 29 | 19056867 |
| Pubmed | 1.23e-05 | 13 | 408 | 4 | 32266253 | ||
| Pubmed | Differential gene expression in migrating cortical interneurons during mouse forebrain development. | 1.23e-05 | 13 | 408 | 4 | 20151419 | |
| Pubmed | SUCO TOM1L2 FLNA FLNB FN1 ERO1A FBXO11 NUDT16L1 SPATA1 NPHP3 INTS13 VCAN OTUD4 HMGXB3 TCAF1 RAPGEF6 ITGA9 DCAF5 AREL1 BMP8B BRD8 PAN2 ADAMTS18 UMAD1 BRWD1 RHBDF1 CPSF6 RALGPS2 HEATR1 ANKRD50 | 1.53e-05 | 1084 | 408 | 30 | 11544199 | |
| Pubmed | 1.57e-05 | 5 | 408 | 3 | 10777529 | ||
| Pubmed | 1.57e-05 | 5 | 408 | 3 | 11493006 | ||
| Pubmed | Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development. | 1.57e-05 | 5 | 408 | 3 | 17251066 | |
| Pubmed | 1.57e-05 | 5 | 408 | 3 | 26492470 | ||
| Pubmed | Isolation of cDNAs from a mouse astroglial cell line by a subtracted cDNA library. | 1.57e-05 | 5 | 408 | 3 | 1701491 | |
| Pubmed | MAP1B AP2A1 SORCS2 PLEKHA5 SYNCRIP TOM1L2 FLNA FLNB FN1 ANK2 GIT1 DPYSL4 PABPC1 VCAN OTUD4 ABLIM2 DHX36 DENND2A NAT9 IQGAP1 ITPR2 DIP2A PTPRA ARHGAP44 WDR1 DNAH6 PRRC2B DPP6 CACNA2D1 DPYSL3 CLASP1 WDR7 PABPC3 SLC4A10 TNR RPL4 | 1.70e-05 | 1431 | 408 | 36 | 37142655 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | WDR81 SOCS6 FANCA PLEKHA5 ABCC2 FNDC3B VLDLR EPB41L5 NUDT16L1 ERGIC3 CNKSR3 INPP5A B2M PSMD7 SIRPA ITFG1 PTPRM MAP4K2 TMED1 WDR7 STXBP5 PALS1 LRBA | 1.70e-05 | 719 | 408 | 23 | 35337019 |
| Pubmed | The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. | 1.70e-05 | 14 | 408 | 4 | 8575766 | |
| Pubmed | 1.71e-05 | 28 | 408 | 5 | 22002062 | ||
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 1.71e-05 | 28 | 408 | 5 | 27002738 | |
| Pubmed | ABCA2 ERMP1 PLEKHA5 KCNT1 SPG11 HMGXB3 ANKS3 DHX36 DENND2A IQGAP1 STAB1 SUPT6H PAN2 SATB2 UFL1 LRRK1 ANKRD50 ABCA5 HPS5 | 1.95e-05 | 529 | 408 | 19 | 14621295 | |
| Pubmed | Structure, chromosomal localization, and expression of 12 genes of the MAGE family. | 2.30e-05 | 15 | 408 | 4 | 7927540 | |
| Pubmed | ACOX1 GUF1 AP2A1 MSMO1 ALDH3A1 DCTPP1 EPB41L5 CPD TXNRD2 NBAS ADPGK MTHFD2 PTK7 RMND1 TMED1 CLASP1 UFL1 LARS2 CBR4 PALS1 P4HA1 AASS | 2.49e-05 | 686 | 408 | 22 | 28380382 | |
| Pubmed | ACACB STUB1 MRPS35 PLEKHH1 TBC1D32 ZDBF2 TPK1 RAB3GAP1 RNF123 INTS13 OTUD4 MYBL2 VPS13A PRRC2B FAT4 SATB2 MUC16 USP6 AASS IRAK3 CDH17 | 2.61e-05 | 638 | 408 | 21 | 31182584 | |
| Pubmed | ABCA2 POMT2 HSPG2 ERGIC3 LAMP3 POGLUT3 ERAP1 ITFG1 CHPF P4HA1 | 2.61e-05 | 164 | 408 | 10 | 32409323 | |
| Cytoband | 4p16.1 | SORCS2 USP17L24 USP17L5 USP17L6P ABLIM2 USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 WDR1 USP17L13 USP17L12 USP17L11 USP17L10 | 4.66e-19 | 79 | 408 | 17 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | SORCS2 USP17L24 USP17L5 USP17L6P ABLIM2 USP17L22 USP17L15 USP17L21 USP17L20 DGKQ USP17L19 USP17L18 USP17L17 WDR1 USP17L13 USP17L12 USP17L11 USP17L10 | 2.08e-12 | 222 | 408 | 18 | chr4p16 |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq28 | 1.35e-04 | 213 | 408 | 9 | chrXq28 | |
| Cytoband | Xq28 | 1.93e-04 | 176 | 408 | 8 | Xq28 | |
| GeneFamily | Fibronectin type III domain containing | EPOR PRTG COL14A1 MPL FNDC3B COL7A1 FN1 ASTN1 PTPRB PTPRD PTPRM ASTN2 LIFR CNTN3 TNR | 1.09e-08 | 160 | 260 | 15 | 555 |
| GeneFamily | Cadherin related | 9.05e-08 | 17 | 260 | 6 | 24 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | PRTG PDGFRA PDGFRB HSPG2 PTK7 PTPRD PTPRM ADAMTSL1 PAPLN CNTN3 ALPK2 | 2.19e-05 | 161 | 260 | 11 | 593 |
| GeneFamily | ADAMTS like | 9.86e-05 | 7 | 260 | 3 | 947 | |
| GeneFamily | Regulatory factor X family | 1.56e-04 | 8 | 260 | 3 | 1153 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.06e-04 | 21 | 260 | 4 | 813 | |
| GeneFamily | WD repeat domain containing | WDR81 PLRG1 DCAF13 STXBP5L DCAF5 DMXL1 WDR1 MLST8 BRWD1 WDR7 STXBP5 LRBA | 4.30e-04 | 262 | 260 | 12 | 362 |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 2.04e-03 | 18 | 260 | 3 | 498 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.04e-03 | 18 | 260 | 3 | 1160 | |
| GeneFamily | MAGE family | 2.54e-03 | 40 | 260 | 4 | 1136 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.54e-03 | 40 | 260 | 4 | 321 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 REC114 USP17L1 DDX4 USP17L4 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 1.27e-19 | 86 | 405 | 21 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L1 USP17L4 ERO1A USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 THSD1 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 4.38e-17 | 112 | 405 | 21 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L1 HMOX1 ALDH3A1 USP17L4 USP17L5 XDH VCAN USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 HGSNAT USP17L10 USP17L8 | 5.30e-17 | 160 | 405 | 24 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L1 SPC25 HMOX1 PIAS3 NID2 USP17L4 KLF6 USP17L5 PM20D1 ERGIC3 USP17L6P ABTB1 USP17L22 USP17L15 USP17L21 NAT9 USP17L20 DGKQ USP17L19 USP17L18 CABYR USP17L17 USP17L3 USP17L13 DDR1 USP17L2 USP17L12 USP17L11 HGSNAT USP17L10 ROM1 USP17L8 | 2.48e-09 | 647 | 405 | 33 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 USP17L1 PEX14 METTL1 CEACAM21 PKD1 SORCS2 HEMK1 NID2 USP17L4 FN1 USP17L5 NBAS XIRP2 INTS13 USP17L6P USP17L22 USP17L15 USP17L21 POGLUT3 TRMT10B NAT9 ERAP1 USP17L20 MTHFD2 PGPEP1 USP17L19 ITPR2 USP17L18 USP17L17 PTPRM USP17L3 USP17L13 USP17L2 USP17L12 STXBP5 USP17L11 USP17L10 CBR4 P4HA1 ROM1 USP17L8 | 7.37e-07 | 1198 | 405 | 42 | MM1062 |
| Coexpression | NABA_CORE_MATRISOME | THSD4 COL6A5 COL14A1 SPARCL1 HSPG2 NID2 COL7A1 FN1 VCAN RELN IMPG1 COL21A1 IMPG2 NDNF LAMA2 PAPLN TNR | 1.55e-06 | 275 | 405 | 17 | M5884 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L1 SPC25 HMOX1 PIAS3 SEC61A1 NID2 USP17L4 USP17L5 PM20D1 ERGIC3 USP17L6P ABTB1 ZC3H12C USP17L22 USP17L15 USP17L21 CLSTN3 NAT9 USP17L20 PSMB4 DGKQ USP17L19 SLC30A1 USP17L18 CABYR PMPCA USP17L17 PTPRM USP17L3 GNA15 TTC13 USP17L13 DDR1 USP17L2 USP17L12 USP17L11 HGSNAT USP17L10 ROM1 USP17L8 | 3.25e-06 | 1226 | 405 | 41 | MM979 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP | PABPC1 TPK1 EMC7 PSMD7 ITGA1 PTPRD RMND1 FAT4 RFX3 LFNG PABPC3 TLL1 KCTD3 | 4.11e-06 | 177 | 405 | 13 | MM479 |
| Coexpression | NABA_MATRISOME | THSD4 SERPINF1 COL6A5 FGF6 COL14A1 SPARCL1 BMP8A PLXNA3 SEMA4F HSPG2 NID2 COL7A1 FN1 VCAN CTSK RELN BRINP3 IMPG1 ADAM20 GDF2 FREM2 BMP8B COL21A1 ADAMTS18 IMPG2 NDNF ADAMTSL1 C1QL3 LAMA2 MUC16 PAPLN ADAMTS13 FREM3 P4HA1 TLL1 TNR | 4.67e-06 | 1026 | 405 | 36 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | THSD4 COL6A5 COL14A1 SPARCL1 HSPG2 NID2 COL7A1 FN1 VCAN RELN IMPG1 IMPG2 NDNF LAMA2 PAPLN TNR | 5.38e-06 | 270 | 405 | 16 | MM17057 |
| Coexpression | NABA_MATRISOME | THSD4 SERPINF1 COL6A5 FGF6 COL14A1 SPARCL1 BMP8A PLXNA3 SEMA4F HSPG2 NID2 COL7A1 FN1 VCAN CTSK RELN BRINP3 IMPG1 ADAM20 GDF2 FREM2 BMP8B ADAMTS18 IMPG2 NDNF ADAMTSL1 C1QL3 LAMA2 MUC16 PAPLN ADAMTS13 FREM3 P4HA1 TLL1 TNR | 7.97e-06 | 1008 | 405 | 35 | MM17056 |
| Coexpression | HAY_BONE_MARROW_STROMAL | THSD4 PRTG PDGFRA PDGFRB FZD8 FAT1 SNX7 PLEKHA5 COL14A1 SPARCL1 PLEKHH2 HSPG2 NID2 COL7A1 FN1 ANK2 CTSK DENND2A ITGA1 PTPRM COL21A1 CACNA2D1 DPYSL3 SATB2 DRD1 ARHGEF28 RHBDF1 LIFR TLL1 | 1.03e-05 | 767 | 405 | 29 | M39209 |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_ONLY | 1.10e-05 | 10 | 405 | 4 | MM1122 | |
| Coexpression | GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP | ERMP1 ADARB2 PKHD1 BMP8A KCNT1 DPYSL4 PHYHD1 PBLD DPYSL3 FAM3A CNTN3 | 1.12e-05 | 139 | 405 | 11 | M485 |
| Coexpression | GSE13229_MATURE_VS_INTMATURE_NKCELL_UP | RNLS MAOB BEND4 PLEKHH1 LY6G6D SNX7 OPALIN CNGA2 PLXNA3 ZAN TCAF1 NKX3-1 MUC16 | 1.54e-05 | 200 | 405 | 13 | M3213 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PRTG ABCA2 MAP1B ACOX1 MAP6D1 ERMP1 SOCS6 LIN9 FZD8 PLXNA3 FLNB CNKSR3 MARF1 ABTB1 ASTN1 CTSK RELN CYP2J2 INPPL1 SLC30A1 ITPR2 PER3 ALMS1 PTPRM CEP95 WDR1 NDNF DDR1 CACNA2D1 DPYSL3 CPSF6 C1QL3 RALGPS2 SLC45A4 P4HA1 TNR | 2.19e-05 | 1102 | 405 | 36 | M2369 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | PRTG ACACB ACOX1 ERMP1 PLEKHH1 TBC1D32 TOM1L2 FLNB KLF6 EPB41L5 RNF213 CTSK TCAF1 ERAP1 INPP5A ITGA1 PTPRB PER3 ALMS1 DDR1 CACNA2D1 DPYSL3 WDR7 CAT UFL1 SLC45A4 CBR4 LIFR MROH1 | 2.63e-05 | 807 | 405 | 29 | M16651 |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | HMOX1 ZSCAN30 FNDC3B VLDLR RNF213 LAMP3 SLC2A12 PCDHA9 ERAP1 ITGA1 ITFG1 ITPR2 PER3 PTPRM ADAMTS18 BRWD1 | 2.86e-05 | 309 | 405 | 16 | M1973 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PRTG ABCA2 MAP1B ACOX1 MAP6D1 ERMP1 SOCS6 LIN9 FZD8 PLXNA3 FLNB CNKSR3 MARF1 ABTB1 ASTN1 CTSK RELN CYP2J2 INPPL1 SLC30A1 ITPR2 PER3 ALMS1 PTPRM CEP95 WDR1 NDNF DDR1 CACNA2D1 DPYSL3 CPSF6 C1QL3 RALGPS2 SLC45A4 P4HA1 TNR | 3.31e-05 | 1124 | 405 | 36 | MM1070 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | PDGFRB EXT2 ERMP1 MSMO1 SUCO SEC61A1 POMT2 HSPG2 FLNA FLNB CPD CLSTN1 EMC7 PSMD7 SLC30A1 IQGAP1 TNRC18 TTC13 CHPF TMED1 DDR1 APMAP HGSNAT SLC45A4 P4HA1 FAM3A | 4.28e-05 | 703 | 405 | 26 | MM1055 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | PKD1 EEF2K PLXNA3 RNF213 HYDIN CACNA1B PTCHD4 ABCA5 SLC4A10 CNTN3 CSMD1 | 5.81e-05 | 166 | 405 | 11 | M39026 |
| Coexpression | GSE13306_TREG_VS_TCONV_UP | SORCS2 ADPGK MYO16 RAPGEF6 INPP5A BMP8B PER3 ADAMTS18 ASTN2 CACNA1B ARHGEF28 PLA2G4E | 6.44e-05 | 198 | 405 | 12 | M3229 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | PDGFRB EXT2 ERMP1 MSMO1 SUCO SEC61A1 POMT2 HSPG2 FLNA FLNB CPD CLSTN1 EMC7 PSMD7 SLC30A1 IQGAP1 TNRC18 TTC13 TMED1 DDR1 APMAP HGSNAT SLC45A4 P4HA1 FAM3A | 6.76e-05 | 681 | 405 | 25 | M5314 |
| Coexpression | GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN | STUB1 FBL ENPP3 TXN2 FLNA SIGLEC7 ZC3H12C MTHFD2 IRF1 TTC13 IRAK3 LRMDA | 7.10e-05 | 200 | 405 | 12 | M8058 |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN | PPM1H CC2D2A XDH POGLUT3 NAT9 PHF8 SLC30A1 ITPR2 LPCAT2 RMND1 WDR7 TLL1 | 7.10e-05 | 200 | 405 | 12 | M8651 |
| Coexpression | GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP | EPOR AGL SUCO VLDLR FN1 PHYHD1 BRINP3 STAB1 BRWD1 CACNA2D1 TLL1 RCAN2 | 7.10e-05 | 200 | 405 | 12 | M7335 |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP | ACOX1 SERPINF1 PHYHD1 POGLUT3 STAB1 PTPRB DPYSL3 RALGPS2 HGSNAT LIFR IRAK3 | 7.59e-05 | 171 | 405 | 11 | M6746 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP | 8.88e-05 | 174 | 405 | 11 | M1113 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | ACACB MAP1B TRPC4 SERPINF1 PEX14 SNX7 COL14A1 EEF2K PLEKHH2 HSPG2 FLNA COL7A1 ANK2 ITGA1 ITGA9 PER3 WDR1 NDNF DPYSL3 RCAN2 | 9.62e-05 | 493 | 405 | 20 | M19391 |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | FAT1 MSMO1 AGL PLEKHA5 SUCO NID2 RELN CYP2J2 B2M FREM2 P4HA1 | 1.14e-04 | 179 | 405 | 11 | M39308 |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_DN | 1.35e-04 | 73 | 405 | 7 | M1561 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 1.74e-04 | 128 | 405 | 9 | M1966 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | PDGFRA PDGFRB ENPP3 SERPINF1 COL6A5 CPED1 FAT1 COL14A1 SPARCL1 PLEKHH2 FNDC3B HSPG2 NID2 FN1 ANK2 XDH CPD VCAN CTSK DENND2A POGLUT3 ITGA1 CACNA2D1 DPYSL3 LAMA2 LIFR CD36 CSMD1 | 9.34e-09 | 445 | 379 | 28 | GSM777043_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | PPM1H PLEKHH1 GUF1 PKHD1 L3HYPDH ABCC2 SYNCRIP DMGDH VLDLR EPB41L5 PM20D1 SLC35F1 PABPC1 OTUD4 RAPGEF6 CYP2J2 CDHR2 PBLD ITGA1 BRD8 CEP95 VPS13A MSS51 BRWD1 CNDP1 CACNA2D1 SATB2 ARHGEF28 C1QL3 CD36 FAM3A HPS5 | 6.69e-06 | 758 | 379 | 32 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#2_top-relative-expression-ranked_1000 | MAP1B PDGFRA SLC35D3 SEMA4F SLC35F1 ASTN1 CACNA1B FAT4 C1QL3 TLL1 CNTN3 | 3.85e-05 | 138 | 379 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | MAP1B LIN9 PLEKHH1 FZD8 ACBD3 PPM1E EPB41L5 DPYSL4 ZDBF2 SLC35F1 DDR1 DPYSL3 LARS2 CDH8 | 5.66e-05 | 225 | 379 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 SPARCL1 PLEKHH2 FN1 ANK2 VCAN MYO16 SLC9A9 PTK7 PTPRD COL21A1 RALGPS2 LIFR RCAN2 | 3.51e-13 | 200 | 400 | 18 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MAOB PDGFRB SERPINF1 COL6A5 COL14A1 SPARCL1 PLEKHH2 FN1 ANK2 VCAN MYO16 SLC9A9 PTK7 LURAP1L PTPRD COL21A1 RALGPS2 RCAN2 | 3.51e-13 | 200 | 400 | 18 | 44a68bacdb3d5bf563bd35952176995850933a81 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MAOB PDGFRB SERPINF1 COL6A5 COL14A1 SPARCL1 PLEKHH2 FN1 ANK2 VCAN MYO16 SLC9A9 PTK7 LURAP1L PTPRD COL21A1 RALGPS2 RCAN2 | 3.51e-13 | 200 | 400 | 18 | dc61016c61729f69649cfb21f6264e685ce83dea |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | PDGFRB SERPINF1 COL6A5 CPED1 COL14A1 SPARCL1 PLEKHH2 FN1 ANK2 VCAN MYO16 SLC9A9 PTK7 PTPRD COL21A1 LIFR RCAN2 | 3.71e-12 | 199 | 400 | 17 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MAOB PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 ANK2 VCAN MYO16 DENND2A SLC9A9 PTK7 PTPRD COL21A1 RALGPS2 RCAN2 | 3.71e-12 | 199 | 400 | 17 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | MAOB PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 NID2 ANK2 VCAN MYO16 SLC9A9 PTK7 PTPRD COL21A1 LIFR RCAN2 | 4.02e-12 | 200 | 400 | 17 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 PDGFRA PDGFRB TRPC4 CPED1 ADARB2 COL14A1 ITGA11 VCAN ITGA1 PTK7 COL21A1 FAT4 ADAMTSL1 LAMA2 LFNG | 3.19e-11 | 196 | 400 | 16 | a12dd986df65c36f248cf10815c3b8b6238613b0 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 PDGFRA PDGFRB TRPC4 CPED1 ADARB2 COL14A1 ITGA11 VCAN ITGA1 PTK7 COL21A1 FAT4 ADAMTSL1 LAMA2 LFNG | 3.19e-11 | 196 | 400 | 16 | 3e6803587d8566fd08cb8b290be3b6461743d79c |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | COL14A1 SPARCL1 PLEKHH2 FN1 VCAN SLC9A9 LURAP1L PTPRD COL21A1 NDNF FAT4 LAMA2 LIFR PTAR1 CNTN3 IRAK3 | 3.45e-11 | 197 | 400 | 16 | 11a4c417f035e554431a8f03be13b5eefa3530c0 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 NID2 FN1 ANK2 VCAN MYO16 DENND2A PTK7 PTPRD COL21A1 LIFR | 4.01e-11 | 199 | 400 | 16 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 FNDC3B NID2 ANK2 VCAN MYO16 DENND2A CLSTN3 PTK7 PTPRD COL21A1 | 4.01e-11 | 199 | 400 | 16 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 SPARCL1 PLEKHH2 ANK2 MYO16 PTK7 LURAP1L PTPRD COL21A1 RALGPS2 LIFR RCAN2 | 4.33e-11 | 200 | 400 | 16 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 SPARCL1 PLEKHH2 ANK2 MYO16 PTK7 LURAP1L PTPRD COL21A1 RALGPS2 LIFR RCAN2 | 4.33e-11 | 200 | 400 | 16 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAOB PDGFRB TRPC4 CPED1 COL14A1 SPARCL1 PLEKHH2 FN1 ANK2 VCAN DENND2A SLC9A9 ITGA1 COL21A1 DPYSL3 LAMA2 | 4.33e-11 | 200 | 400 | 16 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | SPC25 PPM1H HSPG2 FLNB CPD VCAN B2M ITGA9 ITPR2 PTPRB ADAMTSL1 ANKRD50 TLL1 IRAK3 LRMDA | 2.46e-10 | 192 | 400 | 15 | c0c34785a7bdf461722029b322e9184e3d9b3c26 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAOB PDGFRB SERPINF1 COL6A5 CPED1 COL14A1 PLEKHH2 FN1 ANK2 MYO16 DENND2A SLC9A9 PTPRD COL21A1 RALGPS2 | 2.46e-10 | 192 | 400 | 15 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAOB PDGFRB SERPINF1 COL6A5 CPED1 COL14A1 PLEKHH2 ANK2 MYO16 DENND2A SLC9A9 PTPRD COL21A1 ASTN2 RALGPS2 | 2.64e-10 | 193 | 400 | 15 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAOB PDGFRB SERPINF1 COL6A5 CPED1 COL14A1 PLEKHH2 FN1 ANK2 MYO16 DENND2A SLC9A9 LURAP1L PTPRD RALGPS2 | 2.84e-10 | 194 | 400 | 15 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | PDGFRB COL14A1 SPARCL1 PLEKHH2 FN1 VCAN PTK7 LURAP1L PTPRD COL21A1 CACNA2D1 FAT4 LAMA2 LIFR IRAK3 | 3.05e-10 | 195 | 400 | 15 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 PDGFRA PDGFRB TRPC4 CPED1 ADARB2 COL14A1 ITGA11 VCAN ITGA1 PTK7 COL21A1 ADAMTSL1 LAMA2 RCAN2 | 3.52e-10 | 197 | 400 | 15 | b349f8e96d61a4c296af64711e11fc44459a9413 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 PDGFRA PDGFRB TRPC4 CPED1 ADARB2 COL14A1 ITGA11 VCAN ITGA1 PTK7 COL21A1 ADAMTSL1 LAMA2 RCAN2 | 3.52e-10 | 197 | 400 | 15 | c2e390653d5dee7e731c1840cfdab41987dede9b |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MAOB PDGFRB SERPINF1 COL6A5 COL14A1 SPARCL1 PLEKHH2 VCAN MYO16 PTK7 LURAP1L PTPRD COL21A1 RALGPS2 RCAN2 | 3.78e-10 | 198 | 400 | 15 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | THSD4 PDGFRA PDGFRB SERPINF1 CPED1 FAT1 FLNA DENND2A TCAF1 ITGA9 PTK7 NDNF FAT4 LAMA2 ADAMTS13 | 4.05e-10 | 199 | 400 | 15 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | PDGFRB COL14A1 SPARCL1 PLEKHH2 FN1 VCAN ITGA1 LURAP1L PTPRD COL21A1 CACNA2D1 FAT4 LAMA2 LIFR IRAK3 | 4.05e-10 | 199 | 400 | 15 | a09292de4c4447b8eee55d401808e43b817321cc |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA ADARB2 PLEKHH2 STXBP5L SLC35F1 VCAN MYO16 BRINP3 DPP6 TLL1 SLC4A10 CNTN3 CSMD1 LRMDA TNR | 4.35e-10 | 200 | 400 | 15 | 961858738ce35db8760c8c2e136f8369bc444ccf |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA ADARB2 PLEKHH2 STXBP5L SLC35F1 VCAN MYO16 BRINP3 DPP6 TLL1 SLC4A10 CNTN3 CSMD1 LRMDA TNR | 4.35e-10 | 200 | 400 | 15 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA ADARB2 PLEKHH2 STXBP5L SLC35F1 VCAN MYO16 BRINP3 DPP6 TLL1 SLC4A10 CNTN3 CSMD1 LRMDA TNR | 4.35e-10 | 200 | 400 | 15 | cc3409518f8b436ea92deb955e81114b3f410ff7 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA ADARB2 PLEKHH2 STXBP5L SLC35F1 VCAN MYO16 BRINP3 DPP6 TLL1 SLC4A10 CNTN3 CSMD1 LRMDA TNR | 4.35e-10 | 200 | 400 | 15 | c24a3099e3d96d8b72f6d05286bb355d661a0377 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | THSD4 PDGFRA PDGFRB SERPINF1 CPED1 FAT1 SPARCL1 FLNA DENND2A TCAF1 ITGA1 PTK7 NDNF LAMA2 ADAMTS13 | 4.35e-10 | 200 | 400 | 15 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA ADARB2 PLEKHH2 STXBP5L SLC35F1 VCAN MYO16 BRINP3 DPP6 TLL1 SLC4A10 CNTN3 CSMD1 LRMDA TNR | 4.35e-10 | 200 | 400 | 15 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | PDGFRA ADARB2 PLEKHH2 STXBP5L SLC35F1 VCAN MYO16 BRINP3 DPP6 TLL1 SLC4A10 CNTN3 CSMD1 LRMDA TNR | 4.35e-10 | 200 | 400 | 15 | 310cd53db1c137f6af74e6ae682221d7ac27310c |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | THSD4 MAP1B PDGFRB CPED1 COL14A1 SPARCL1 FLNA ITGA11 FN1 VCAN ITGA1 CACNA2D1 ADAMTSL1 RCAN2 | 1.04e-09 | 180 | 400 | 14 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | PDGFRB CPED1 MSMO1 COL14A1 SPARCL1 PLEKHH2 FN1 VCAN SLC9A9 ITGA1 PTPRD CACNA2D1 LAMA2 LIFR | 1.70e-09 | 187 | 400 | 14 | a9316e2818217ec5feae9cf8816f7249803caee6 |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | SPC25 PPM1H HSPG2 FLNB FN1 ITGA1 ITGA9 ITPR2 PTPRB PTPRM ADAMTSL1 TLL1 IRAK3 LRMDA | 1.96e-09 | 189 | 400 | 14 | c81787a8c662db5d7814c583dd64562857629e81 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAOB PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 ANK2 VCAN MYO16 DENND2A SLC9A9 PTPRD COL21A1 RALGPS2 | 2.24e-09 | 191 | 400 | 14 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | MAP1B PDGFRB CPED1 FAT1 COL14A1 KCNT1 ITGA11 SLC35F1 NPAS4 DENND2A ITGA1 CACNA2D1 CSMD1 RCAN2 | 2.24e-09 | 191 | 400 | 14 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAOB PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 ANK2 MYO16 DENND2A SLC9A9 PTK7 PTPRD COL21A1 RALGPS2 | 2.40e-09 | 192 | 400 | 14 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB TRPC4 CPED1 SPARCL1 FLNA ITGA11 FN1 VCAN ITGA1 COL21A1 DPYSL3 LAMA2 RCAN2 | 2.74e-09 | 194 | 400 | 14 | ebb038f94f49f5c655578d1b018676e10c6b7e3c |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 PDGFRA PDGFRB TRPC4 CPED1 ADARB2 COL14A1 ITGA11 VCAN ITGA1 COL21A1 ADAMTSL1 LAMA2 RCAN2 | 2.93e-09 | 195 | 400 | 14 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | THSD4 PDGFRA SERPINF1 CPED1 COL14A1 HSPG2 FN1 VCAN CTSK POGLUT3 IRF1 CHPF DPYSL3 LAMA2 | 2.93e-09 | 195 | 400 | 14 | 223f5f07dc28fa13a09bb589884c58043c7928c7 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | COL14A1 SPARCL1 PLEKHH2 FN1 VCAN SLC9A9 LURAP1L PTPRD COL21A1 CACNA2D1 FAT4 LAMA2 LIFR IRAK3 | 3.13e-09 | 196 | 400 | 14 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 PDGFRA PDGFRB TRPC4 CPED1 ADARB2 COL14A1 ITGA11 VCAN ITGA1 PTK7 COL21A1 ADAMTSL1 LAMA2 | 3.35e-09 | 197 | 400 | 14 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | PDGFRB COL14A1 SPARCL1 PLEKHH2 FN1 VCAN SLC9A9 LURAP1L PTPRD COL21A1 CACNA2D1 FAT4 LAMA2 IRAK3 | 3.35e-09 | 197 | 400 | 14 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | COL14A1 SPARCL1 PLEKHH2 FN1 VCAN SLC9A9 LURAP1L PTPRD COL21A1 CACNA2D1 FAT4 LAMA2 LIFR IRAK3 | 3.57e-09 | 198 | 400 | 14 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 NID2 VCAN MYO16 DENND2A PTK7 LURAP1L COL21A1 RALGPS2 | 3.81e-09 | 199 | 400 | 14 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | MAOB PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 NID2 ANK2 VCAN MYO16 DENND2A PTK7 LURAP1L | 3.81e-09 | 199 | 400 | 14 | 211c3a08f2d484ab7a3368006767289088f0d957 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 NID2 VCAN MYO16 DENND2A PTK7 LURAP1L COL21A1 RALGPS2 | 3.81e-09 | 199 | 400 | 14 | ba586690f88fd051f449753bfe7603a2cb431782 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | MAOB PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 NID2 ANK2 VCAN MYO16 DENND2A PTK7 LURAP1L | 3.81e-09 | 199 | 400 | 14 | 1a0add79f4e34078b3475eb11c85a4234bda197c |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | MAP1B PDGFRA PDGFRB SERPINF1 COL14A1 SPARCL1 NID2 FN1 ANK2 VCAN CTSK CHPF DPYSL3 LAMA2 | 4.07e-09 | 200 | 400 | 14 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | MAP1B PDGFRA PDGFRB SERPINF1 COL14A1 SPARCL1 NID2 FN1 ANK2 VCAN CTSK CHPF DPYSL3 LAMA2 | 4.07e-09 | 200 | 400 | 14 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDGFRA PDGFRB SERPINF1 CPED1 COL14A1 SPARCL1 ITGA11 ANK2 VCAN DENND2A SLC9A9 FAT4 ADAMTSL1 LAMA2 | 4.07e-09 | 200 | 400 | 14 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | THSD4 PDGFRA SERPINF1 CPED1 FAT1 SPARCL1 VCAN DENND2A ITGA9 PTK7 LURAP1L NDNF CACNA2D1 FAT4 | 4.07e-09 | 200 | 400 | 14 | a799fc7bb83ad0524362cb5010df949741fb7bf3 |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | MAP1B PDGFRA PDGFRB SERPINF1 COL14A1 SPARCL1 NID2 FN1 ANK2 VCAN CTSK CHPF DPYSL3 LAMA2 | 4.07e-09 | 200 | 400 | 14 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAOB PDGFRB TRPC4 COL14A1 SPARCL1 PLEKHH2 FN1 ANK2 VCAN DENND2A SLC9A9 COL21A1 DPYSL3 LAMA2 | 4.07e-09 | 200 | 400 | 14 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | PDGFRB SERPINF1 COL6A5 CPED1 COL14A1 SPARCL1 PLEKHH2 FN1 ANK2 VCAN MYO16 PTK7 PTPRD COL21A1 | 4.07e-09 | 200 | 400 | 14 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | MAP1B PDGFRA PDGFRB SLC35D3 COL14A1 SPARCL1 PLEKHH2 NID2 ITGA11 PPM1E COL21A1 LAMA2 PAPLN | 8.21e-09 | 177 | 400 | 13 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | MAP1B PDGFRA PDGFRB SLC35D3 COL14A1 SPARCL1 PLEKHH2 NID2 ITGA11 PPM1E COL21A1 LAMA2 PAPLN | 8.21e-09 | 177 | 400 | 13 | db222faaecbe5600da39277243c4e7e764eb63c9 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDGFRA PDGFRB PLEKHH2 FN1 BRINP3 ITGA1 CACNA2D1 FAT4 LAMA2 PAPLN ADAMTS13 CNTN3 EPB42 | 1.07e-08 | 181 | 400 | 13 | b116c68393d8836bac080f81a8fcbeb52e0403e7 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT1 PKHD1 ZAN STXBP5L SLC35F1 XIRP2 HYDIN MYO16 RELN FREM2 PTPRD FAT4 CSMD1 | 1.31e-08 | 184 | 400 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT1 PKHD1 ZAN STXBP5L SLC35F1 XIRP2 HYDIN MYO16 RELN FREM2 PTPRD FAT4 CSMD1 | 1.31e-08 | 184 | 400 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT1 PKHD1 ZAN STXBP5L SLC35F1 XIRP2 HYDIN MYO16 RELN FREM2 PTPRD FAT4 CSMD1 | 1.31e-08 | 184 | 400 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDGFRA PDGFRB CPED1 ZFYVE9 COL14A1 SPARCL1 PLEKHH2 RELN GDF2 ASTN2 CACNA2D1 PAPLN ADAMTS13 | 1.40e-08 | 185 | 400 | 13 | f814ec9d4ade717a0109398e9768d0d66f09317b |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDGFRA PDGFRB CPED1 ZFYVE9 COL14A1 SPARCL1 PLEKHH2 RELN GDF2 ASTN2 CACNA2D1 PAPLN ADAMTS13 | 1.40e-08 | 185 | 400 | 13 | 40e958511790e84321da5ccf735f9974c06a0263 |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDGFRA PDGFRB CPED1 ZFYVE9 COL14A1 SPARCL1 PLEKHH2 RELN GDF2 ASTN2 CACNA2D1 PAPLN ADAMTS13 | 1.40e-08 | 185 | 400 | 13 | 5f2eeba80aff145e85cfd81e2890a155406badb9 |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SORCS2 PKHD1 EPB41L5 TRIM71 ITGA9 ARHGAP44 FHIP1A NDNF DDR1 DPP6 ARHGEF28 SLC26A5 RORC | 1.59e-08 | 187 | 400 | 13 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | THSD4 ACACB PLEKHA5 ANK2 XIRP2 ACOT11 TRPM7 PTPRM B4GALNT3 LAMA2 CD36 ALPK2 RCAN2 | 1.80e-08 | 189 | 400 | 13 | 5e80c47f63980904c4c1ff02c201b67b456a0974 |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | MAOB PDGFRA SPARCL1 PLEKHH2 FN1 ANK2 VCAN DENND2A ITGA1 COL21A1 CACNA2D1 DPYSL3 LAMA2 | 1.92e-08 | 190 | 400 | 13 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 PDGFRA PDGFRB TRPC4 CPED1 COL14A1 NID2 ITGA11 VCAN ITGA1 ITGA9 LAMA2 IRAK3 | 2.04e-08 | 191 | 400 | 13 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 PDGFRA PDGFRB TRPC4 CPED1 COL14A1 NID2 ITGA11 VCAN ITGA1 ITGA9 LAMA2 IRAK3 | 2.04e-08 | 191 | 400 | 13 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB TRPC4 CPED1 SPARCL1 FLNA ITGA11 FN1 ITGA1 COL21A1 DPYSL3 LAMA2 RCAN2 | 2.04e-08 | 191 | 400 | 13 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDGFRA PDGFRB SERPINF1 COL14A1 SPARCL1 HSPG2 NID2 ITGA11 VCAN CTSK DPYSL3 ADAMTSL1 LAMA2 | 2.17e-08 | 192 | 400 | 13 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | PDGFRB SERPINF1 COL14A1 SPARCL1 NID2 VLDLR ANK2 ASTN1 BRINP3 FAT4 DPYSL3 ADAMTSL1 LAMA2 | 2.17e-08 | 192 | 400 | 13 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAOB PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 ANK2 MYO16 DENND2A SLC9A9 PTPRD COL21A1 RALGPS2 | 2.17e-08 | 192 | 400 | 13 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDGFRA PDGFRB SERPINF1 COL14A1 SPARCL1 HSPG2 NID2 ITGA11 VCAN CTSK DPYSL3 ADAMTSL1 LAMA2 | 2.17e-08 | 192 | 400 | 13 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDGFRA PDGFRB SERPINF1 COL14A1 SPARCL1 HSPG2 NID2 ITGA11 VCAN CTSK DPYSL3 ADAMTSL1 LAMA2 | 2.17e-08 | 192 | 400 | 13 | ac1477433704573f95111eee6263b93668d2845e |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | MAP1B PDGFRA PLEKHA5 COL14A1 PLEKHH2 FN1 DENND2A BRINP3 ITGA1 CACNA2D1 FAT4 DPYSL3 LAMA2 | 2.31e-08 | 193 | 400 | 13 | e6b75be08e33c1de079fb5c02f0b4468128b369c |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | SPC25 PPM1H HSPG2 FLNB B2M ITGA1 ITGA9 PTPRB ADAMTSL1 LIFR TLL1 IRAK3 LRMDA | 2.31e-08 | 193 | 400 | 13 | 2531266bc57339d4e2b22a88817008e32b8c1598 |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | SPC25 SPARCL1 HSPG2 FLNB FN1 B2M ITGA1 ITGA9 PTPRB ADAMTSL1 TLL1 IRAK3 LRMDA | 2.31e-08 | 193 | 400 | 13 | 01c2df9206f1527c578e808978e58196c35e72f5 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL6A5 PKHD1 PLEKHH2 ASTN1 HYDIN CACNA1B KCTD19 LAMA2 PTCHD4 AASS TLL1 CNTN3 | 2.44e-08 | 160 | 400 | 12 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL6A5 PKHD1 PLEKHH2 ASTN1 HYDIN CACNA1B KCTD19 LAMA2 PTCHD4 AASS TLL1 CNTN3 | 2.44e-08 | 160 | 400 | 12 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | XDH CLSTN1 INPP5A ITGA1 THSD1 SLC30A1 STAB1 PTPRB PTPRM LARS2 LIFR CD36 LRP5 | 2.46e-08 | 194 | 400 | 13 | f159ef8541d75a4e98468947f231bb463bec922c |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRA PDGFRB SERPINF1 COL14A1 NID2 ITGA11 FN1 VCAN CTSK ITGA1 DPYSL3 LAMA2 | 2.46e-08 | 194 | 400 | 13 | 02b8102be9414d6964cd71019613edff6d88b893 |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAOB PDGFRA SERPINF1 CPED1 COL14A1 HSPG2 VLDLR VCAN CTSK POGLUT3 CHPF ADAMTSL1 LAMA2 | 2.61e-08 | 195 | 400 | 13 | 69a29d03e664b72f32d41876510c62345c3aed31 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 MAP1B PDGFRB TRPC4 CPED1 FLNA ITGA11 FN1 VCAN ITGA1 COL21A1 DPYSL3 LAMA2 | 2.61e-08 | 195 | 400 | 13 | dd281a249854800f737dc22e0f375f66dfb5cf5f |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRA PDGFRB TRPC4 CPED1 COL14A1 ITGA11 SLC35F1 VCAN ITGA1 COL21A1 ADAMTSL1 LAMA2 | 2.61e-08 | 195 | 400 | 13 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 MAP1B PDGFRB TRPC4 CPED1 FLNA ITGA11 FN1 VCAN ITGA1 COL21A1 DPYSL3 LAMA2 | 2.61e-08 | 195 | 400 | 13 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAOB PDGFRA SERPINF1 CPED1 COL14A1 HSPG2 VLDLR VCAN CTSK POGLUT3 CHPF ADAMTSL1 LAMA2 | 2.61e-08 | 195 | 400 | 13 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAOB PDGFRA SERPINF1 CPED1 COL14A1 HSPG2 VLDLR VCAN CTSK POGLUT3 CHPF ADAMTSL1 LAMA2 | 2.61e-08 | 195 | 400 | 13 | 9cef6f18664518060af7c192310dddce6d70345a |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRB TRPC4 CPED1 SPARCL1 FLNA ITGA11 FN1 SLC35F1 ITGA1 COL21A1 LAMA2 RCAN2 | 2.78e-08 | 196 | 400 | 13 | b8759e6231e0254797d6c30930407b79440c57bb |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | PRTG PKHD1 ABCC2 ZAN HYDIN CDHR2 FREM2 TRIM60 CACNA1B LARS2 ABCA5 CNTN3 | 2.81e-08 | 162 | 400 | 12 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B PDGFRB COL6A5 CPED1 SPARCL1 PLEKHH2 VCAN DENND2A SLC9A9 ITGA1 FAT4 DPYSL3 LAMA2 | 2.95e-08 | 197 | 400 | 13 | 44673c38384453207871d3fd8e8ba9093cc06bc5 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | PDGFRB COL14A1 SPARCL1 PLEKHH2 FN1 VCAN SLC9A9 LURAP1L PTPRD COL21A1 LAMA2 LIFR IRAK3 | 2.95e-08 | 197 | 400 | 13 | 31a1852911bda38543916585fda34255fd62a134 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRA PDGFRB SERPINF1 COL14A1 ITGA11 FN1 VCAN CTSK ITGA1 COL21A1 DPYSL3 LAMA2 | 2.95e-08 | 197 | 400 | 13 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | COL14A1 PLEKHH2 FN1 VCAN SLC9A9 LURAP1L PTPRD COL21A1 LAMA2 LIFR PTAR1 CNTN3 IRAK3 | 2.95e-08 | 197 | 400 | 13 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | MAOB PDGFRA PDGFRB COL14A1 PLEKHH2 FN1 ANK2 VCAN DENND2A PTPRD CACNA2D1 DPYSL3 LAMA2 | 3.13e-08 | 198 | 400 | 13 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | PDGFRB COL14A1 SPARCL1 PLEKHH2 FN1 VCAN DENND2A ITGA1 COL21A1 CACNA2D1 FAT4 LAMA2 LIFR | 3.13e-08 | 198 | 400 | 13 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | MAP1B PDGFRA PDGFRB TRPC4 CPED1 NID2 ITGA11 FN1 VCAN ITGA1 LAMA2 LRRK1 IRAK3 | 3.13e-08 | 198 | 400 | 13 | ca26ca460856b1faaa3e83766da6abdf63af2b51 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | PDGFRA PDGFRB SERPINF1 COL6A5 COL14A1 PLEKHH2 NID2 ANK2 VCAN MYO16 DENND2A CLSTN3 PTK7 | 3.32e-08 | 199 | 400 | 13 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | FAT1 PKHD1 FLNA CLSTN1 VCAN PABPC1L SYNC ITGA1 IQGAP1 CEP95 DDR1 VPS13D ALPK2 | 3.32e-08 | 199 | 400 | 13 | 174f6013af6eafa577f84205a62927f2b367fda3 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PDGFRA MSMO1 BMP8A PLEKHH2 STXBP5L SLC35F1 VCAN ASTN1 HYDIN DPP6 CNTN3 CSMD1 TNR | 3.32e-08 | 199 | 400 | 13 | 19a97e27a4758e794ce7246d295e112b47931a48 |
| Computational | Genes in the cancer module 257. | FAT1 DCTPP1 SEC61A1 DNAJC4 CLSTN1 INPPL1 CABYR PMPCA CHPF MAP4K2 LRP5 HDAC10 | 6.18e-05 | 156 | 213 | 12 | MODULE_257 |
| Drug | Methamphetamine | EPOR ACACB MAOB PDGFRA SPC25 HMOX1 DYSF EEF2K HSPG2 FLNA VLDLR FLNB AMPD3 FN1 SLC39A3 KLF6 XDH PLCD3 RNF123 SLC12A3 KLF7 CHTF18 SLC2A12 ADPGK NPAS4 IMPG1 CDHR2 MTHFD2 INPPL1 ITGA1 THSD1 ITPR2 CABYR CEP95 SUPT6H KCNJ14 ASTN2 POLL RMND1 EXOC7 MAP4K2 BRWD1 CACNA2D1 DPYSL3 DRD1 RHBDF1 RALGPS2 CAT SPAG9 P4HA1 PADI6 HDAC10 CSMD1 | 5.45e-08 | 1401 | 391 | 53 | ctd:D008694 |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 8.61e-26 | 46 | 395 | 20 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L1 USP17L4 USP17L24 USP17L5 USP17L6P USP17L22 USP17L15 USP17L21 USP17L20 PSMD7 USP17L19 USP17L18 USP17L17 USP17L3 USP17L13 USP17L2 USP17L12 USP17L11 USP17L10 USP17L8 | 4.03e-23 | 69 | 395 | 21 | DOID:1682 (implicated_via_orthology) |
| Disease | Malignant neoplasm of breast | MAGEA1 EPOR CATSPERE FBL TRPC4 RPS6KB2 HMOX1 DYSF CNGA2 FNDC3B NID2 FLNA FLNB COL7A1 FN1 ANK2 PPM1E XDH PABPC1 DOP1A ITGA9 PTPRD PER3 ASTN2 RMND1 TMED1 PCDHGB6 LAMA2 CAT RFX2 TLL1 LRBA | 2.41e-05 | 1074 | 395 | 32 | C0006142 |
| Disease | cortical surface area measurement | THSD4 EFCAB5 PRTG RNLS ENPP3 DYSF CPED1 PKD1 PKHD1 FLNB ITGA11 ZAN TRIM71 CLSTN1 VCAN CNKSR3 CTSK MYO16 SLC9A9 RELN INPP5A PGPEP1 SYNC PMPCA ADAMTS18 ASTN2 WDR1 CACNA2D1 DPYSL3 SATB2 ADAMTSL1 CPSF6 RALGPS2 LAMA2 SLC45A4 TLL1 SLC4A10 | 3.11e-05 | 1345 | 395 | 37 | EFO_0010736 |
| Disease | Colorectal Carcinoma | MAP1B ADARB2 FAT1 NPAP1 PKHD1 ABCC2 COL7A1 FN1 ANK2 PPM1E SIGLEC7 ERGIC3 INTS13 CLSTN3 TRPM7 CABYR PTPRD VPS13A PAN2 ADAMTS18 SATB2 LIFR BRF1 ABCA5 | 3.11e-05 | 702 | 395 | 24 | C0009402 |
| Disease | joint hypermobility measurement | 7.31e-05 | 33 | 395 | 5 | EFO_0007905 | |
| Disease | Disproportionate short stature | 7.85e-05 | 77 | 395 | 7 | C0878659 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGTITDLPDHLLSYD | 101 | C9J7I0 | |
| STDHLPDVIITEEYT | 96 | Q8WWZ7 | |
| YVSGFHPSDIEVDLL | 46 | P61769 | |
| VVLDQDTGHPYLFVS | 301 | Q96KV6 | |
| VVSFALYPEEILDTH | 11 | P43235 | |
| TISLGSHTVLDFYEP | 126 | Q3KRA9 | |
| PPILEDYVHVTSTEG | 171 | Q8WVB6 | |
| VTTPADAVIGHYSLL | 106 | P16452 | |
| PEVAESTDHYIGFET | 476 | Q76B58 | |
| DAISAEGLFYSEVHP | 481 | Q9BRR6 | |
| HVPYSVSETRLEEAL | 76 | Q8N129 | |
| LYTDGISFDPALIHD | 461 | Q9BQT9 | |
| TATLTIDRVEYTGHP | 386 | Q5SY80 | |
| IDRVEYTGHPLEIAV | 391 | Q5SY80 | |
| HDYLLITEDGSFSEP | 981 | Q96PZ7 | |
| SSGAEEALVDHTPYL | 2766 | P13611 | |
| EALVDHTPYLSIATT | 2771 | P13611 | |
| DLHYTTEGIPVLIVG | 41 | P0CG13 | |
| YDTILVEVSGHDAPP | 271 | Q9NQI0 | |
| PSALEHSIQYSGEVR | 416 | P04040 | |
| VVDESPAHGETLITY | 646 | A4D0V7 | |
| PREVTVDTTLAGYHL | 381 | P51589 | |
| HISSYLPNDTVESGI | 1106 | Q96NH3 | |
| VTDDIAPGYHSIVQR | 736 | Q9H0E9 | |
| GDPHFNIVITDYSSE | 816 | Q6L9W6 | |
| SIHSYEEGTDPEIFL | 2581 | Q8IZF6 | |
| LSEATAHIYPGDSAV | 276 | Q86TB3 | |
| VDSFYHPLEVDVILT | 241 | O43506 | |
| VVTESSLYGEHLAQP | 361 | O95264 | |
| DYASNSVVLHLEPGD | 211 | Q5VWW1 | |
| DELYIHSEPLGVVLV | 96 | P30838 | |
| AEGENVHLSVVYLPE | 46 | Q3KPI0 | |
| TYEEELTTPLHVAAS | 111 | Q8WXI3 | |
| VPHYAEADIVTLQGV | 566 | Q08345 | |
| DHVVPEPESSLTEAY | 106 | Q14195 | |
| VISGVLKETEPHYVA | 121 | Q3ZCU0 | |
| LIYDETDIPHNSETI | 4591 | Q6V0I7 | |
| ISGTHEENPYSLLEI | 106 | P10767 | |
| SEYGHLADVDPLSTS | 271 | Q6ZU67 | |
| EYVEPHELKEVSQTG | 241 | Q9UDR5 | |
| HSVISYEQELPDLTE | 1856 | Q8TCU4 | |
| FETISLIIHYDSEPN | 311 | O95782 | |
| SPEEYSSLLHEAGAT | 511 | P52824 | |
| DEDDAIYHVTSPALG | 466 | Q8WXI4 | |
| VYHVNLEGVIETAPD | 291 | Q3LIE5 | |
| PVYIAEGNHTSELRS | 761 | Q5JWR5 | |
| STELEDDAIYSVHVP | 536 | Q9Y2X7 | |
| EGEVVSALGKTYHPD | 91 | Q6H8Q1 | |
| VHISSVYNDVPVTEG | 291 | O75952 | |
| SLHDPDGLVATYISE | 376 | Q9HDC9 | |
| PLLVAAYEGHVDVVD | 751 | Q9ULJ7 | |
| EFPSVTLYVDGTSHE | 466 | O94985 | |
| NLVYLIPHAVGSSED | 386 | P21728 | |
| FGGPVISSLYHEETI | 141 | Q9BR61 | |
| VGVHIADVSYFVPEG | 406 | Q8IYB7 | |
| VQGVHELYDLEETPV | 331 | Q5RIA9 | |
| LKHSVDATYEEQGPS | 1371 | Q00975 | |
| DHYILQVVASDRGTP | 1491 | Q9H251 | |
| YSQELHLPEGVEIIS | 951 | Q9Y485 | |
| EEEPLHTILGKTVYT | 146 | Q9NV06 | |
| TTGSPENEILTVHYL | 126 | Q7Z2K6 | |
| EAANEIHYIPSVLIG | 196 | O14525 | |
| RSHGEVPEVSIYSVI | 1141 | O75129 | |
| DTDPGHADLVLYITR | 166 | Q76LX8 | |
| PVEVDSAGSYISHDI | 66 | Q8TE60 | |
| PYDLTVDSLDVHAGR | 366 | Q01432 | |
| VSAADLEALISGHYP | 206 | Q9UGP5 | |
| VIPECGETYHSDLAE | 656 | P46940 | |
| AHIYVKTVAGSEEPV | 101 | Q96PE5 | |
| EKYELHAGTESTPSV | 146 | Q14206 | |
| HPYSGVTVDITIQEG | 476 | Q9H2T7 | |
| AQTLLASEELPHVYE | 211 | Q7Z4M0 | |
| PHLTEGIIVDNDVYS | 286 | Q15042 | |
| EDPVTGSAHAVLSSY | 226 | P30039 | |
| LHYSVPEEAEHGTFV | 31 | Q9Y5H5 | |
| SETPGQLLHADYEES | 816 | Q01804 | |
| PIYIEASSSHVTEGQ | 2926 | P98160 | |
| GDARLHSPYEITTDL | 491 | Q9NS39 | |
| HIPVEVVPDSTSDLY | 196 | P10914 | |
| VIDEELLGDGHSYSP | 116 | P28070 | |
| DPSHDLKGSVVIYDV | 161 | Q9UK05 | |
| GDESGPLAYHITLVE | 1366 | Q14571 | |
| LIHTYPVGEDSLVSD | 206 | Q9NVM9 | |
| LNLIDTPGHVDFSYE | 136 | Q8N442 | |
| GLSHTEYQIVTDPGD | 441 | Q8TD20 | |
| QEVEEYHIPSLSEAL | 471 | Q17RG1 | |
| HISYSIVASDLEPLA | 486 | Q9Y5F9 | |
| ASLYVGDLHPDVTEA | 11 | P11940 | |
| TGVYTEHVFTDPLGV | 911 | O60271 | |
| SHYLGSDVTLTPEVE | 1411 | Q6ZRR7 | |
| GSLQEIYHATGPLEE | 96 | Q12851 | |
| VEEYSHLFTIQGSDP | 101 | Q6GTS8 | |
| VSHITVPDDFEGVYT | 1991 | O00763 | |
| VYPLSENVEGTAHTE | 426 | Q8N1W1 | |
| APVDDVTLDYLTALH | 356 | Q01484 | |
| YTPLHISAREGQVDV | 531 | Q01484 | |
| VLGSLEALEPVHYEE | 371 | P27338 | |
| LLETIDVHSGYDIPL | 221 | Q15800 | |
| VYTLHPSGEIVADSV | 471 | Q6IE37 | |
| VIESISPDGHEYIYV | 561 | P16234 | |
| VPADDVSGNKHETIY | 651 | P0C881 | |
| VPADDVSGNKHETIY | 651 | B2RC85 | |
| TSTPLDREEQAVYHL | 3081 | Q14517 | |
| HPGSLDETTYERLAE | 86 | Q16595 | |
| HSITELGPYTLDRDS | 13576 | Q8WXI7 | |
| THSITELGPYTLDRD | 13886 | Q8WXI7 | |
| VYSELHSVVAEVGVP | 61 | Q504Q3 | |
| STFELVLGPDQHAYT | 231 | Q6TGC4 | |
| PYAELEEVSSHVGKV | 91 | P59103 | |
| LAPGDVDNYEVTLSH | 666 | P23467 | |
| LDHLAEVTPALEYLS | 66 | Q9H2I8 | |
| SYRPQLEGEHLVSVT | 551 | Q2Q1W2 | |
| LGTHTIPDYEVLSNE | 261 | Q5TKA1 | |
| VPTSELHEQVTLSYG | 321 | Q8NES3 | |
| ATPVDEGVAEDTYSH | 1531 | P46821 | |
| VLHITENGPTEVDYS | 1676 | P46821 | |
| GIDVKEADPTGHSYV | 156 | P43355 | |
| RISYPSLHEEALGEE | 301 | P43361 | |
| KEVDPAGHSYILVTA | 166 | P43362 | |
| GIDVKEVDPTSHSYV | 276 | P43364 | |
| VTLTHVEYPAGDLSG | 16 | Q86YN1 | |
| SHVETFLTRPGDYDE | 271 | Q4VC12 | |
| LLVLTHGADPESYAV | 171 | Q38SD2 | |
| IPTETTYHTLEEGVV | 171 | Q69YI7 | |
| ASTLAQEEPYEEIIH | 321 | Q9Y6X6 | |
| SEVPELSEYVSVPDH | 531 | Q17R60 | |
| LSEYVSVPDHFLEDT | 536 | Q17R60 | |
| GIPEARESSEYIVAH | 56 | Q9Y5R4 | |
| ELDLLSVTIEGPSHY | 3671 | Q2LD37 | |
| SATSGEDYHPVSEEI | 2296 | Q5SZK8 | |
| VIPESYSHVLAEFES | 6 | Q9UPZ3 | |
| VITLRSEPQYDHTAG | 271 | Q9UPZ3 | |
| GSSVEHVVEFGLDYP | 706 | O75197 | |
| EIPIGIYRTESHVFS | 1016 | Q5JUK3 | |
| VQGVHELYDLEETPV | 331 | Q8IUF1 | |
| VQGVHELYDLEETPV | 331 | Q9BRT8 | |
| SDDTVVAIPYGSRHI | 201 | Q8N6G6 | |
| LPIGHYQSVVELSAE | 366 | Q69YN2 | |
| GEGIAASPEHIDVVY | 636 | Q08426 | |
| LEDASLEVGESHQPY | 216 | Q12766 | |
| VTEGLTDVILYHQPD | 266 | O60506 | |
| DPVILATAGYDHTVR | 11 | Q9BVC4 | |
| SVSVTHPELKVGDYF | 386 | Q9NZ08 | |
| VSHVSDIIGPDGLVY | 186 | A6NHQ2 | |
| PGVYIVSTKFADEHV | 2066 | O75369 | |
| DLIGTSILSYLHPED | 301 | P56645 | |
| VYGLDLHPTIDVLVT | 291 | O43660 | |
| QDAHLYETVPVVDGS | 446 | P51805 | |
| SEEKVVTYDHIGPNV | 366 | Q14642 | |
| LGDSVDLHVYEIPVE | 36 | Q9NXJ5 | |
| VHVLSAYASIEPLTG | 141 | Q14999 | |
| SIVTGLYEESHGIVA | 76 | Q9Y6X5 | |
| TTEVHPELYVDKSRG | 51 | Q9Y282 | |
| ALGEAPDHSYESLRV | 46 | Q13011 | |
| HVSDIVGPDGLVYAV | 176 | P22087 | |
| HEDAVYGLSVSPVND | 141 | Q96JK2 | |
| LGELEVVAYSSPGHS | 851 | Q96JK2 | |
| TAAPRAILTGHDYEV | 2686 | P50851 | |
| HDSSVIPDGAEISSY | 41 | Q8TB73 | |
| TVSDPETIYQGIKHA | 311 | Q9UQV4 | |
| DVFSLDYHVDGPIAT | 636 | Q96CW5 | |
| EVVTVRVPTHEEGSY | 401 | Q9H3P7 | |
| DLSISTAQDEVYLHP | 631 | P24043 | |
| IYLLDDPLSAVDAHV | 781 | Q92887 | |
| VHDTGYFSALPSLEE | 16 | O75840 | |
| PHASYGGIVSVETDL | 231 | Q8N159 | |
| LEELVTVAHYDSPEA | 566 | A6NGR9 | |
| VTFSVEYSLEDPDHG | 746 | Q9UKX5 | |
| HPNILELAAYFTETE | 221 | Q9Y616 | |
| HLERITEEGYVPTAQ | 166 | P30679 | |
| VYHVPGSLLAARDTE | 321 | O60431 | |
| FVYTLHPSGEIVADS | 521 | Q6IE36 | |
| ASLYVGDLHPDVTEA | 11 | Q4VXU2 | |
| ASEYHISIAANETVP | 956 | P56199 | |
| TTVPLLLGYLDEHTE | 581 | Q8NDA8 | |
| PYAVSELAGHQTSAE | 51 | P36578 | |
| ATYEEILGVPHASEQ | 696 | A2RRP1 | |
| ILGVPHASEQRYDAE | 701 | A2RRP1 | |
| LTLGHEVGYSIPQED | 121 | Q8TE96 | |
| VDSPAIDYHISLAQS | 991 | Q8IVE3 | |
| YHVASDTEKIIREGP | 91 | Q9UPT5 | |
| LAASIAPEIYGHEDV | 336 | P33993 | |
| ASLYVGDLHPDVTEA | 11 | Q9H361 | |
| DGREVYAVTHDLTPT | 2736 | P78509 | |
| HEIDSASPLYELGRA | 276 | Q9UNX9 | |
| HILALYAVVSVGDPV | 246 | Q13882 | |
| IGNDTTHYIIDDLEP | 471 | Q2VWP7 | |
| VLELPGTTHEYLLEG | 566 | Q2VWP7 | |
| HYIPKETDGTEGTVE | 181 | Q8WY54 | |
| SNPITGDLETVHYRI | 366 | P13674 | |
| TEEGIVLESPHYAVK | 106 | Q8N3R9 | |
| AEALGIPVTDHTYED | 311 | Q7L5N7 | |
| EEEIVLRSYPASGHT | 441 | Q14112 | |
| EDTVTPDDHLLTVLY | 141 | Q3MJ16 | |
| HEGTLVFVASYDDPA | 141 | P98173 | |
| SPIVFEAAYSLSEHV | 571 | Q13797 | |
| GDSIYDIIDPADHLT | 116 | Q8IUM7 | |
| AVEQHVRYETTGPAL | 381 | Q9H461 | |
| DHVFPDTGVSLLAAY | 106 | O14531 | |
| QELYIESVIEPGTHT | 536 | A4FU69 | |
| HLRGLETTATYDPET | 146 | Q15067 | |
| ISVLSPGTVITEHYG | 271 | Q6ICH7 | |
| YSIEKVIPSTGDSEH | 161 | Q9BYE9 | |
| LGDYDLAEHSPELVS | 171 | Q9HCM4 | |
| PEHDYGILQSTIVDV | 1706 | Q9C0G6 | |
| LTAAHPESEELIAQY | 741 | Q05DH4 | |
| SEEELGLVHSPEYVS | 56 | Q969S8 | |
| GLVHSPEYVSLVRET | 61 | Q969S8 | |
| EVSFEVTYHPTEVGK | 4586 | Q4G0P3 | |
| PESLTLQVYETVGHS | 721 | Q9P2K1 | |
| GHDQIDLYDDVISPS | 26 | Q16630 | |
| TGSHEDYRVFISAEP | 3956 | Q9UFH2 | |
| RAQEYLETLPSGEHS | 976 | Q9ULE3 | |
| VHIPTDIYEGSTIVL | 166 | P54289 | |
| TIVTGLYPESHGIID | 211 | O14638 | |
| LAGEPTHDTDTLYDS | 901 | Q86XK2 | |
| EGLHSVDVTYDGSPV | 1326 | P21333 | |
| SEYIISCHPVGTDEE | 2221 | P02751 | |
| TPSGITYDRKDIEEH | 246 | Q9UNE7 | |
| EHRTYLDIEPITGFT | 366 | P16671 | |
| HATSEDAVVRGYSIP | 381 | Q6VVX0 | |
| ELQEIASEPDSTHVY | 301 | Q05707 | |
| HTDIELSGLLPNTEY | 496 | Q05707 | |
| DSHVIEGLEPGTEYE | 676 | Q05707 | |
| VASEVYHGPELECTV | 716 | Q53EP0 | |
| SDPYLSSVSHIVLDE | 321 | Q9H2U1 | |
| YEDLSSAGDITEPHS | 531 | O15360 | |
| PVYADVVFLVDSSDH | 26 | A8TX70 | |
| LRLYVETEDGHSVDP | 216 | Q7Z5Y6 | |
| VQGVHELYDLEETPV | 331 | Q5JTY5 | |
| VAEINHPVTTYKTGD | 816 | O75976 | |
| LLESPYITGHVLVVD | 216 | Q8N4T8 | |
| VLEIPLGSYDSGEHL | 86 | Q96P44 | |
| YELLGVHPGASTEEV | 36 | Q9NNZ3 | |
| IDTFVGHDVVEPGSY | 671 | Q9BZC7 | |
| YTLSIHELGPQEEES | 211 | O15033 | |
| ETLSQHSDGIVEYGP | 416 | Q96GE4 | |
| DEHLIPQLGYVATSD | 616 | Q9NSI6 | |
| ESGPSYEFHLTRQEI | 426 | Q96HE7 | |
| SYLDTLADDVPGHQT | 181 | Q8IV03 | |
| RVYAELTVSHQSPGE | 576 | Q9UI17 | |
| ETLQPKTYGHSSVEE | 1521 | Q9Y4F3 | |
| RSDVAVPLTLHGYSD | 21 | Q9H9H5 | |
| VPLTLHGYSDLDSEE | 26 | Q9H9H5 | |
| PLDLHTAASIGQYEV | 36 | Q6ZW76 | |
| LEPVGSEHAQDTYLV | 356 | P19235 | |
| HTEVAYDPEGILGTI | 491 | Q68CP4 | |
| VGRTEPELLVAHAYT | 121 | P09601 | |
| DGLEPDTEYTVHVRA | 741 | Q02388 | |
| ITILHGISETYDVSP | 331 | Q9H583 | |
| LYTDPQIHTETGTDF | 281 | O00418 | |
| VHDIPSGSYVVEVVS | 86 | Q9NPA0 | |
| YHFSVPEDVVLGTAI | 281 | P55286 | |
| YTELPHGAISEDQAV | 141 | Q9H773 | |
| DVTTGLVEHSYFERP | 226 | Q14689 | |
| FTDTTHYPLLLVVDG | 616 | P42658 | |
| LRLYVETEDGHSVDP | 216 | P34820 | |
| GVDTDPHTNTGYVII | 501 | Q12864 | |
| VPDEHFSTLLAYLEG | 136 | Q9BRJ6 | |
| DVAEAVIYVLSTPAH | 231 | Q6UWP2 | |
| LAVIVPEGVHALYED | 51 | Q9NUM3 | |
| ILYAENVHTPDTDIS | 6 | O75923 | |
| VTELYHDPSNDAITA | 356 | Q9Y597 | |
| QETGHLYISKVEPSD | 176 | Q9P232 | |
| GEVSPHQDASFLYTE | 151 | Q5SRE7 | |
| PDAGLAEYLFDTHTL | 221 | Q8N4E7 | |
| PALSHGDYEITINSL | 101 | P42702 | |
| LHIPSAELEDSGTYT | 276 | P09619 | |
| TVLSGPEATVEHVYL | 1251 | P98161 | |
| DSYIASQGPLLHTIE | 601 | P18433 | |
| GHLDPDTEYEISVLL | 341 | P28827 | |
| HGEEQRITIEPGTSY | 556 | P23468 | |
| SEDLAVHLYPGAVTI | 446 | Q86X27 | |
| IHYSVPEETDKGSFV | 31 | Q9Y5H4 | |
| GVADPIIYVLATDHS | 301 | Q9UNW8 | |
| ETESVGDVTYPAHRD | 81 | O95868 | |
| DGTHTDFYVLPDTAL | 1626 | P0C091 | |
| HFPIEIDSTDYVSSG | 146 | P82673 | |
| TSPEHVVYEGETVTR | 131 | Q9H7C4 | |
| VAALGDLTDLPTYEH | 491 | Q10713 | |
| DTEHGPLTAQYVIAV | 181 | Q5M8T2 | |
| EHSIVDPTYIEDFLL | 431 | Q8TEU7 | |
| SVLLVDPASHTLYVG | 66 | O95754 | |
| DPASHTLYVGARDTI | 71 | O95754 | |
| ADGHPLLVTTDTAYL | 421 | O95754 | |
| ASIPEHLAYGSVITV | 331 | Q9UKY4 | |
| VEFSTDLIDSYPGHE | 296 | Q7Z6K3 | |
| LHVDPDLYTLLFGES | 226 | Q8IVB4 | |
| PEEIYSIGDSVLIHF | 971 | O43897 | |
| ATPEAIYGTSHVAIS | 301 | Q15031 | |
| VVSHEDYLVEAQLTP | 61 | Q9Y4C2 | |
| PVGHYEEVELTETSV | 41 | Q9UBS0 | |
| SVILVGENPASHSYV | 71 | P13995 | |
| IIDHSGDPAEGVYKT | 426 | Q7Z494 | |
| YLVEHRVAEATGETP | 651 | P48378 | |
| YLVEHRVAQATGETP | 636 | P48380 | |
| LGLPTEAYISVEEVH | 131 | P51665 | |
| PDTSLFHLVYVDAIA | 331 | P58743 | |
| PSVTEYRLDGHTISD | 366 | P10244 | |
| PANVAHSVYVLEDSI | 71 | Q9Y255 | |
| DHYSLSVTVPVLIAG | 651 | Q6ZW05 | |
| EGILHEELSTYPDEV | 266 | Q96CC6 | |
| PIDHGSLTVQDDYIF | 341 | Q96PQ0 | |
| VGLYPDQEAIHTLSA | 636 | Q9UPW6 | |
| DEVTVTIPHDIYVFG | 456 | O15357 | |
| AHSSGEEREIQYAPL | 426 | Q9Y286 | |
| TNVDPVGESVSYSIH | 196 | P78324 | |
| SLGHISTDYPLAETI | 76 | Q9BRY0 | |
| LASHGYVEVTSLPRD | 191 | Q9NWS8 | |
| AETEPERHLGSYLLD | 91 | Q99801 | |
| LEAKGPVTDVAYSHD | 486 | O75083 | |
| IVLSSSSYEPHEAEV | 2896 | P08F94 | |
| VVDSVEYDFHLLPSG | 71 | P30520 | |
| HGLVELDDKPTVVYT | 336 | Q9BZV3 | |
| STVTYHLLGPQEEGE | 286 | O75381 | |
| SYPEIIITGHADGSV | 446 | Q5T5C0 | |
| SVEGDLHTLEKSPEY | 361 | Q9NZP6 | |
| VDVQEYSADPHAIAG | 311 | Q17R89 | |
| SGLSEALLPVVHEYV | 261 | Q9UNH6 | |
| HPDSEDLAFLYGTIL | 231 | Q96EM0 | |
| SSSELVELHVFYVPE | 31 | Q5VX52 | |
| HLGNVYSPSTVILDE | 141 | Q5VX52 | |
| GAQTYPEIIITGHAD | 456 | Q9Y2K9 | |
| DYEVSDSAPHLEGLA | 181 | Q9HBM1 | |
| HTELSPEAAYDVLSV | 341 | Q969K4 | |
| FLVPDTTYTEAHGLA | 196 | Q8IZ52 | |
| SSGHILVPGIYDEVV | 286 | Q96KN2 | |
| TDLIYFAVDIHSPEV | 231 | Q16280 | |
| GIPHYLRQTEDVAEV | 846 | Q7Z460 | |
| YDGLHVITGTTENSP | 231 | G9CGD6 | |
| YDGLHVITGTTENSP | 231 | Q6P9H4 | |
| HTDLAIEYEVSAVPT | 121 | Q99757 | |
| DDGSTHVYASPAILL | 66 | Q6URK8 | |
| EESILLEHQSVYPFS | 211 | P17032 | |
| HYGPSVITSLDEQDA | 541 | Q9Y6X2 | |
| VALHLFSIDEEQYSP | 246 | Q5BKX6 | |
| TDSYIEVLDGSRVHP | 1046 | Q7KZ85 | |
| TDNHLAPSEEYGLVV | 2146 | Q96JI7 | |
| PTYEDVIAGHILDIS | 3281 | A4UGR9 | |
| LDSRDVVLPTYDITH | 266 | Q7Z4H8 | |
| TYTSLGQETEEEPHV | 391 | Q5T1Q4 | |
| PGSHEESREYSLEEV | 1571 | Q63HN8 | |
| TVHSPDIYRVVVEGE | 2181 | O15417 | |
| GTEYVFPEVLLTEIH | 436 | O95498 | |
| HGISDTFDPYLDIAL | 211 | A6NCW0 | |
| AHLDTPLTEYNIDVD | 441 | Q8NBP0 | |
| EPSTQYLHITEAEED | 1086 | Q9P243 | |
| EGKTVEVPTYDFVTH | 106 | Q9HA47 | |
| HFSVPLSVYEGDTLL | 2001 | Q96RL7 | |
| TVLAYHAPEEQEGLL | 6 | Q86W11 | |
| HGISDTFDPYLDIAL | 211 | A6NCW7 | |
| EAPYASLTEIEHLVQ | 261 | P51449 | |
| PDIHGTYKELLDTVT | 116 | P36955 | |
| GLVTALAHYKDTEVP | 136 | Q03395 | |
| LPAASTILHYERGAE | 246 | O95428 | |
| SGDDISVYVIPLIHG | 496 | Q9ULR3 | |
| TTVPFGVTYLEHSIE | 246 | Q5VYX0 | |
| FGSVLEDPVHAVVYI | 351 | P61619 | |
| HQYSGEDRVLSAPEL | 261 | Q8N3E9 | |
| LTEADYLSSHLTEGP | 91 | Q9BRJ7 | |
| ESVDHYPILVAVTGI | 1141 | Q5XPI4 | |
| HLSVNLEYAPTEGTL | 106 | Q14515 | |
| EPGHVALSNDTVYVD | 31 | Q9NS62 | |
| LEGHYRDDPSVINIS | 1071 | Q6U841 | |
| VGVATALAPLQTDHY | 106 | Q99619 | |
| HGISDTFDPYLDIAL | 211 | D6R9N7 | |
| SSQVGLHPEYREDLE | 256 | Q93063 | |
| PATEYIVNLVAVHGT | 836 | Q92752 | |
| HGISDTFDPYLDIAL | 211 | A8MUK1 | |
| PIDSEVSLDYNIIFH | 911 | Q9HCK1 | |
| HGISDTFDPYLDIAL | 211 | D6R901 | |
| HGISDTFDPYLDIAL | 211 | C9JLJ4 | |
| ASETHSEGSEYEELP | 1131 | Q5JSZ5 | |
| PATVEDYIGILHDAF | 751 | P55017 | |
| HGLVPQIEAATAYTI | 1151 | Q9NY15 | |
| HGISDTFDPYLDIAL | 211 | D6RCP7 | |
| LFTLEELHYSPEGSL | 1206 | P47989 | |
| SGHGILPSYQELVED | 981 | Q2KHR2 | |
| HGISDTFDPYLDIAL | 211 | Q7RTZ2 | |
| VEVTTAPGTVHSYLG | 366 | P40238 | |
| ESVEYEAGHIPSPVI | 751 | Q9UBS9 | |
| VLHSYPESVGREVAN | 21 | Q86X10 | |
| AASYHREILEGSLEP | 136 | Q495X7 | |
| VPVEAASVDYHVSLA | 866 | Q9ULM0 | |
| AVLVESGPVSYHADE | 626 | Q92994 | |
| SHLLSVGYQVPEAEV | 61 | Q6P3V2 | |
| HGISDTFDPYLDIAL | 211 | C9JPN9 | |
| QHPESGEEVVVLLEY | 116 | Q969J2 | |
| REATSVPHIYAIGDV | 346 | Q9NNW7 | |
| HGISDTFDPYLDIAL | 211 | Q0WX57 | |
| EELSHHVEVYRSGPE | 101 | Q6NX49 | |
| EHYPESGEEAVTILE | 111 | P49910 | |
| HGVSDTFDPYLDIAL | 211 | P0C7H9 | |
| HGISDTFDPYLDIAL | 211 | P0C7I0 | |
| PSFTVRDVEHYVGSD | 176 | Q9UPP1 | |
| GVHTVEPTEAGDYKL | 91 | Q13445 | |
| DLGHLYVESTDPQLS | 41 | Q9C0D7 | |
| DEPGLYSHTVLETAD | 2181 | Q9C0G0 | |
| HGISDTFDPYLDIAL | 211 | Q6QN14 | |
| YGTEAAVSPTVGIHL | 101 | Q6UWW9 | |
| ETLVYLTPDSEHALE | 206 | Q6PF06 | |
| EIINSTHASVYEAGP | 296 | Q9Y6M5 | |
| HSALITSVVPGDYDG | 96 | Q8TB96 | |
| ALTSLGYHRVVEIPE | 421 | Q6ZMP0 | |
| SPDLTGVVHIYEELK | 131 | Q6ZVM7 | |
| HEEETRGVISYQTLP | 426 | Q9HAU0 | |
| HGISDTFDPYLDIAL | 211 | D6RA61 | |
| HSTILDYINVVPTAG | 591 | Q96LC7 | |
| HGISDTFDPYLDIAL | 211 | C9J2P7 | |
| HGISDTFDPYLDIAL | 211 | D6RBQ6 | |
| VEPERTTVYQGHTAL | 596 | Q13308 | |
| QYIDHVISPGVTSEA | 1056 | Q9Y4E6 | |
| SEPDHYVVIGAQRDA | 421 | Q9UP52 | |
| SFYEQPDVEGHTSIV | 441 | O14544 | |
| YPTDAVSTEHAVALA | 421 | P51854 | |
| EKHTEQSPTDAYGVI | 81 | Q96QT4 | |
| LHPDEIDTDSAYILF | 1351 | P35125 | |
| GGLVYTITDVLELHD | 191 | Q9UBP6 | |
| HYSVAAGITDKGEVP | 66 | A0A0J9YX75 | |
| PIHTFDLYGSEVVTG | 1871 | Q562E7 | |
| GEHLESYEAEISTRP | 646 | O95405 | |
| SIDYDLNLPDTVTHE | 956 | Q9UBN4 | |
| HGISDTFDPYLDIAL | 211 | Q6R6M4 | |
| EVVHTLDGKEYITPA | 46 | O94874 | |
| YDGSGVVTVETDHPL | 221 | Q9H3S4 | |
| HGISDTFDPYLDIAL | 211 | D6RJB6 | |
| HGISDTFDPYLDIAL | 211 | C9JJH3 | |
| HGISDTFDPYLDIAL | 211 | C9JVI0 | |
| VRYDGSHLVEVTVPS | 1656 | Q9Y493 | |
| VGHTYPAISVVSTDD | 856 | P98155 | |
| YDLQDPRIHTVLSGE | 2266 | Q5THJ4 | |
| STRGYDELVPHQISV | 656 | P35573 | |
| VHETGYFSALPSLEE | 16 | Q99612 | |
| TSHVEEKPYRDGSAE | 191 | Q9BTE0 |